id	sid	tid	token	lemma	pos
aiua-11057	1	1	stesura	stesura	PROPN
aiua-11057	1	2	seveso	seveso	PROPN
aiua-11057	1	3	archivio	archivio	PROPN
aiua-11057	1	4	italiano	italiano	X
aiua-11057	1	5	di	di	X
aiua-11057	1	6	urologia	urologia	PROPN
aiua-11057	1	7	e	e	PROPN
aiua-11057	1	8	andrologia	andrologia	NOUN
aiua-11057	1	9	2023	2023	NUM
aiua-11057	1	10	;	;	PUNCT
aiua-11057	1	11	95	95	NUM
aiua-11057	1	12	,	,	PUNCT
aiua-11057	1	13	1	1	NUM
aiua-11057	1	14	original	original	ADJ
aiua-11057	1	15	paper	paper	NOUN
aiua-11057	1	16	patients	patient	NOUN
aiua-11057	1	17	and	and	CCONJ
aiua-11057	1	18	methods	method	NOUN
aiua-11057	1	19	this	this	PRON
aiua-11057	1	20	is	be	AUX
aiua-11057	1	21	a	a	DET
aiua-11057	1	22	retrospective	retrospective	ADJ
aiua-11057	1	23	study	study	NOUN
aiua-11057	1	24	including	include	VERB
aiua-11057	1	25	patients	patient	NOUN
aiua-11057	1	26	with	with	ADP
aiua-11057	1	27	pathologically	pathologically	ADV
aiua-11057	1	28	proven	prove	VERB
aiua-11057	1	29	stage	stage	NOUN
aiua-11057	1	30	i	i	PRON
aiua-11057	1	31	seminoma	seminoma	VERB
aiua-11057	1	32	,	,	PUNCT
aiua-11057	1	33	who	who	PRON
aiua-11057	1	34	presented	present	VERB
aiua-11057	1	35	to	to	ADP
aiua-11057	1	36	the	the	DET
aiua-11057	1	37	national	national	PROPN
aiua-11057	1	38	cancer	cancer	PROPN
aiua-11057	1	39	institute	institute	PROPN
aiua-11057	1	40	,	,	PUNCT
aiua-11057	1	41	cairo	cairo	PROPN
aiua-11057	1	42	university	university	PROPN
aiua-11057	1	43	,	,	PUNCT
aiua-11057	1	44	during	during	ADP
aiua-11057	1	45	the	the	DET
aiua-11057	1	46	period	period	NOUN
aiua-11057	1	47	from	from	ADP
aiua-11057	1	48	2005	2005	NUM
aiua-11057	1	49	to	to	ADP
aiua-11057	1	50	2019	2019	NUM
aiua-11057	1	51	.	.	PUNCT
aiua-11057	2	1	data	datum	NOUN
aiua-11057	2	2	was	be	AUX
aiua-11057	2	3	retrieved	retrieve	VERB
aiua-11057	2	4	from	from	ADP
aiua-11057	2	5	the	the	DET
aiua-11057	2	6	patients	patient	NOUN
aiua-11057	2	7	'	'	PART
aiua-11057	2	8	medical	medical	ADJ
aiua-11057	2	9	records	record	NOUN
aiua-11057	2	10	.	.	PUNCT
aiua-11057	3	1	the	the	DET
aiua-11057	3	2	collected	collect	VERB
aiua-11057	3	3	data	datum	NOUN
aiua-11057	3	4	included	include	VERB
aiua-11057	3	5	age	age	NOUN
aiua-11057	3	6	,	,	PUNCT
aiua-11057	3	7	pathological	pathological	ADJ
aiua-11057	3	8	subtype	subtype	NOUN
aiua-11057	3	9	,	,	PUNCT
aiua-11057	3	10	post	post	ADJ
aiua-11057	3	11	-	-	ADJ
aiua-11057	3	12	operative	operative	ADJ
aiua-11057	3	13	stage	stage	NOUN
aiua-11057	3	14	,	,	PUNCT
aiua-11057	3	15	date	date	NOUN
aiua-11057	3	16	and	and	CCONJ
aiua-11057	3	17	type	type	NOUN
aiua-11057	3	18	of	of	ADP
aiua-11057	3	19	surgery	surgery	NOUN
aiua-11057	3	20	,	,	PUNCT
aiua-11057	3	21	pre	pre	ADJ
aiua-11057	3	22	&	&	CCONJ
aiua-11057	3	23	post	post	ADJ
aiua-11057	3	24	-	-	ADJ
aiua-11057	3	25	operative	operative	ADJ
aiua-11057	3	26	tumor	tumor	NOUN
aiua-11057	3	27	markers	marker	NOUN
aiua-11057	3	28	,	,	PUNCT
aiua-11057	3	29	details	detail	NOUN
aiua-11057	3	30	of	of	ADP
aiua-11057	3	31	adjuvant	adjuvant	ADJ
aiua-11057	3	32	treatment	treatment	NOUN
aiua-11057	3	33	,	,	PUNCT
aiua-11057	3	34	patterns	pattern	NOUN
aiua-11057	3	35	of	of	ADP
aiua-11057	3	36	failure	failure	NOUN
aiua-11057	3	37	and	and	CCONJ
aiua-11057	3	38	patients	patient	NOUN
aiua-11057	3	39	'	'	PART
aiua-11057	3	40	status	status	NOUN
aiua-11057	3	41	at	at	ADP
aiua-11057	3	42	last	last	ADJ
aiua-11057	3	43	follow	follow	NOUN
aiua-11057	3	44	up	up	ADP
aiua-11057	3	45	.	.	PUNCT
aiua-11057	4	1	all	all	DET
aiua-11057	4	2	patients	patient	NOUN
aiua-11057	4	3	had	have	VERB
aiua-11057	4	4	inguinal	inguinal	ADJ
aiua-11057	4	5	orchiectomy	orchiectomy	NOUN
aiua-11057	4	6	followed	follow	VERB
aiua-11057	4	7	by	by	ADP
aiua-11057	4	8	staging	stage	VERB
aiua-11057	4	9	computed	compute	VERB
aiua-11057	4	10	tomography	tomography	NOUN
aiua-11057	4	11	(	(	PUNCT
aiua-11057	4	12	ct	ct	NOUN
aiua-11057	4	13	)	)	PUNCT
aiua-11057	4	14	of	of	ADP
aiua-11057	4	15	abdomen	abdomen	PROPN
aiua-11057	4	16	&	&	CCONJ
aiua-11057	4	17	pelvis	pelvi	VERB
aiua-11057	4	18	to	to	PART
aiua-11057	4	19	exclude	exclude	VERB
aiua-11057	4	20	nodal	nodal	NOUN
aiua-11057	4	21	or	or	CCONJ
aiua-11057	4	22	distant	distant	ADJ
aiua-11057	4	23	disease	disease	NOUN
aiua-11057	4	24	and	and	CCONJ
aiua-11057	4	25	serum	serum	NOUN
aiua-11057	4	26	tumor	tumor	NOUN
aiua-11057	4	27	marker	marker	NOUN
aiua-11057	4	28	assessments	assessment	NOUN
aiua-11057	4	29	(	(	PUNCT
aiua-11057	4	30	alpha	alpha	NOUN
aiua-11057	4	31	-	-	PUNCT
aiua-11057	4	32	fetoprotein	fetoprotein	ADJ
aiua-11057	4	33	and	and	CCONJ
aiua-11057	4	34	beta	beta	NOUN
aiua-11057	4	35	-	-	PUNCT
aiua-11057	4	36	hcg	hcg	NOUN
aiua-11057	4	37	)	)	PUNCT
aiua-11057	4	38	.	.	PUNCT
aiua-11057	5	1	patients	patient	NOUN
aiua-11057	5	2	who	who	PRON
aiua-11057	5	3	were	be	AUX
aiua-11057	5	4	kept	keep	VERB
aiua-11057	5	5	under	under	ADP
aiua-11057	5	6	active	active	ADJ
aiua-11057	5	7	surveillance	surveillance	NOUN
aiua-11057	5	8	,	,	PUNCT
aiua-11057	5	9	were	be	AUX
aiua-11057	5	10	followed	follow	VERB
aiua-11057	5	11	every	every	DET
aiua-11057	5	12	3	3	NUM
aiua-11057	5	13	months	month	NOUN
aiua-11057	5	14	in	in	ADP
aiua-11057	5	15	the	the	DET
aiua-11057	5	16	first	first	ADJ
aiua-11057	5	17	2	2	NUM
aiua-11057	5	18	years	year	NOUN
aiua-11057	5	19	.	.	PUNCT
aiua-11057	6	1	in	in	ADP
aiua-11057	6	2	each	each	DET
aiua-11057	6	3	visit	visit	NOUN
aiua-11057	6	4	history	history	NOUN
aiua-11057	6	5	and	and	CCONJ
aiua-11057	6	6	physical	physical	ADJ
aiua-11057	6	7	examination	examination	NOUN
aiua-11057	6	8	was	be	AUX
aiua-11057	6	9	performed	perform	VERB
aiua-11057	6	10	,	,	PUNCT
aiua-11057	6	11	serum	serum	PROPN
aiua-11057	6	12	tumor	tumor	PROPN
aiua-11057	6	13	markers	marker	NOUN
aiua-11057	6	14	levels	level	NOUN
aiua-11057	6	15	(	(	PUNCT
aiua-11057	6	16	ldh	ldh	INTJ
aiua-11057	6	17	,	,	PUNCT
aiua-11057	6	18	beta	beta	NOUN
aiua-11057	6	19	-	-	PUNCT
aiua-11057	6	20	hcg	hcg	NOUN
aiua-11057	6	21	,	,	PUNCT
aiua-11057	6	22	alpha	alpha	NOUN
aiua-11057	6	23	-	-	PUNCT
aiua-11057	6	24	fetoprotein	fetoprotein	NOUN
aiua-11057	6	25	)	)	PUNCT
aiua-11057	6	26	were	be	AUX
aiua-11057	6	27	obtained	obtain	VERB
aiua-11057	6	28	,	,	PUNCT
aiua-11057	6	29	and	and	CCONJ
aiua-11057	6	30	imaging	imaging	NOUN
aiua-11057	6	31	was	be	AUX
aiua-11057	6	32	done	do	VERB
aiua-11057	6	33	every	every	DET
aiua-11057	6	34	6	6	NUM
aiua-11057	6	35	months	month	NOUN
aiua-11057	6	36	.	.	PUNCT
aiua-11057	7	1	in	in	ADP
aiua-11057	7	2	the	the	DET
aiua-11057	7	3	third	third	ADJ
aiua-11057	7	4	year	year	NOUN
aiua-11057	7	5	of	of	ADP
aiua-11057	7	6	follow	follow	VERB
aiua-11057	7	7	up	up	ADP
aiua-11057	7	8	,	,	PUNCT
aiua-11057	7	9	the	the	DET
aiua-11057	7	10	interval	interval	NOUN
aiua-11057	7	11	of	of	ADP
aiua-11057	7	12	the	the	DET
aiua-11057	7	13	visits	visit	NOUN
aiua-11057	7	14	was	be	AUX
aiua-11057	7	15	every	every	DET
aiua-11057	7	16	6	6	NUM
aiua-11057	7	17	months	month	NOUN
aiua-11057	7	18	and	and	CCONJ
aiua-11057	7	19	imaging	imaging	NOUN
aiua-11057	7	20	and	and	CCONJ
aiua-11057	7	21	markers	marker	NOUN
aiua-11057	7	22	were	be	AUX
aiua-11057	7	23	ordered	order	VERB
aiua-11057	7	24	annually	annually	ADV
aiua-11057	7	25	.	.	PUNCT
aiua-11057	8	1	in	in	ADP
aiua-11057	8	2	the	the	DET
aiua-11057	8	3	following	following	ADJ
aiua-11057	8	4	years	year	NOUN
aiua-11057	8	5	of	of	ADP
aiua-11057	8	6	follow	follow	VERB
aiua-11057	8	7	up	up	ADP
aiua-11057	8	8	,	,	PUNCT
aiua-11057	8	9	the	the	DET
aiua-11057	8	10	interval	interval	NOUN
aiua-11057	8	11	was	be	AUX
aiua-11057	8	12	annually	annually	ADV
aiua-11057	8	13	with	with	ADP
aiua-11057	8	14	no	no	DET
aiua-11057	8	15	imaging	imaging	NOUN
aiua-11057	8	16	unless	unless	SCONJ
aiua-11057	8	17	clinically	clinically	ADV
aiua-11057	8	18	indicated	indicate	VERB
aiua-11057	8	19	.	.	PUNCT
aiua-11057	9	1	all	all	DET
aiua-11057	9	2	patient	patient	NOUN
aiua-11057	9	3	were	be	AUX
aiua-11057	9	4	adherent	adherent	ADJ
aiua-11057	9	5	to	to	ADP
aiua-11057	9	6	the	the	DET
aiua-11057	9	7	follow	follow	VERB
aiua-11057	9	8	up	up	ADP
aiua-11057	9	9	schedule	schedule	NOUN
aiua-11057	9	10	.	.	PUNCT
aiua-11057	10	1	in	in	ADP
aiua-11057	10	2	patients	patient	NOUN
aiua-11057	10	3	who	who	PRON
aiua-11057	10	4	received	receive	VERB
aiua-11057	10	5	adjuvant	adjuvant	ADJ
aiua-11057	10	6	chemotherapy	chemotherapy	NOUN
aiua-11057	10	7	,	,	PUNCT
aiua-11057	10	8	one	one	NUM
aiua-11057	10	9	cycle	cycle	NOUN
aiua-11057	10	10	of	of	ADP
aiua-11057	10	11	carboplatin	carboplatin	NOUN
aiua-11057	10	12	(	(	PUNCT
aiua-11057	10	13	auc	auc	NOUN
aiua-11057	10	14	7	7	NUM
aiua-11057	10	15	,	,	PUNCT
aiua-11057	10	16	based	base	VERB
aiua-11057	10	17	on	on	ADP
aiua-11057	10	18	the	the	DET
aiua-11057	10	19	formula	formula	NOUN
aiua-11057	10	20	7x	7x	NUM
aiua-11057	10	21	[	[	X
aiua-11057	10	22	glomerular	glomerular	ADJ
aiua-11057	10	23	filtration	filtration	NOUN
aiua-11057	10	24	rate	rate	NOUN
aiua-11057	10	25	(	(	PUNCT
aiua-11057	10	26	gfr	gfr	NOUN
aiua-11057	10	27	,	,	PUNCT
aiua-11057	10	28	ml	ml	NOUN
aiua-11057	10	29	/	/	SYM
aiua-11057	10	30	min	min	NOUN
aiua-11057	10	31	)	)	PUNCT
aiua-11057	10	32	+25	+25	NOUN
aiua-11057	11	1	mg	mg	PROPN
aiua-11057	11	2	]	]	PUNCT
aiua-11057	11	3	was	be	AUX
aiua-11057	11	4	given	give	VERB
aiua-11057	11	5	to	to	ADP
aiua-11057	11	6	all	all	DET
aiua-11057	11	7	patients	patient	NOUN
aiua-11057	11	8	except	except	SCONJ
aiua-11057	11	9	one	one	NUM
aiua-11057	11	10	patient	patient	NOUN
aiua-11057	11	11	who	who	PRON
aiua-11057	11	12	was	be	AUX
aiua-11057	11	13	given	give	VERB
aiua-11057	11	14	two	two	NUM
aiua-11057	11	15	cycles	cycle	NOUN
aiua-11057	11	16	.	.	PUNCT
aiua-11057	12	1	patients	patient	NOUN
aiua-11057	12	2	were	be	AUX
aiua-11057	12	3	kept	keep	VERB
aiua-11057	12	4	under	under	AUX
aiua-11057	12	5	follow	follow	VERB
aiua-11057	12	6	up	up	ADP
aiua-11057	12	7	every	every	DET
aiua-11057	12	8	6	6	NUM
aiua-11057	12	9	months	month	NOUN
aiua-11057	12	10	in	in	ADP
aiua-11057	12	11	the	the	DET
aiua-11057	12	12	first	first	ADJ
aiua-11057	12	13	and	and	CCONJ
aiua-11057	12	14	second	second	ADJ
aiua-11057	12	15	year	year	NOUN
aiua-11057	12	16	then	then	ADV
aiua-11057	12	17	follow	follow	VERB
aiua-11057	12	18	up	up	ADP
aiua-11057	12	19	was	be	AUX
aiua-11057	12	20	annually	annually	ADV
aiua-11057	12	21	,	,	PUNCT
aiua-11057	12	22	with	with	ADP
aiua-11057	12	23	serum	serum	NOUN
aiua-11057	12	24	tumor	tumor	NOUN
aiua-11057	12	25	markers	marker	NOUN
aiua-11057	12	26	(	(	PUNCT
aiua-11057	12	27	ldh	ldh	PROPN
aiua-11057	12	28	,	,	PUNCT
aiua-11057	12	29	beta	beta	NOUN
aiua-11057	12	30	-	-	PUNCT
aiua-11057	12	31	hcg	hcg	NOUN
aiua-11057	12	32	,	,	PUNCT
aiua-11057	12	33	alpha	alpha	NOUN
aiua-11057	12	34	-	-	PUNCT
aiua-11057	12	35	fetoprotein	fetoprotein	NOUN
aiua-11057	12	36	)	)	PUNCT
aiua-11057	12	37	obtained	obtain	VERB
aiua-11057	12	38	at	at	ADP
aiua-11057	12	39	each	each	DET
aiua-11057	12	40	visit	visit	NOUN
aiua-11057	12	41	and	and	CCONJ
aiua-11057	12	42	imaging	imaging	NOUN
aiua-11057	12	43	if	if	SCONJ
aiua-11057	12	44	clinically	clinically	ADV
aiua-11057	12	45	indicated	indicate	VERB
aiua-11057	12	46	.	.	PUNCT
aiua-11057	13	1	in	in	ADP
aiua-11057	13	2	patients	patient	NOUN
aiua-11057	13	3	who	who	PRON
aiua-11057	13	4	received	receive	VERB
aiua-11057	13	5	adjuvant	adjuvant	ADJ
aiua-11057	13	6	radiation	radiation	NOUN
aiua-11057	13	7	radiotherapy	radiotherapy	NOUN
aiua-11057	13	8	;	;	PUNCT
aiua-11057	13	9	the	the	DET
aiua-11057	13	10	field	field	NOUN
aiua-11057	13	11	of	of	ADP
aiua-11057	13	12	radiation	radiation	NOUN
aiua-11057	13	13	was	be	AUX
aiua-11057	13	14	para	para	ADJ
aiua-11057	13	15	-	-	PUNCT
aiua-11057	13	16	aortic	aortic	ADJ
aiua-11057	13	17	lymph	lymph	NOUN
aiua-11057	13	18	nodes	node	NOUN
aiua-11057	13	19	field	field	NOUN
aiua-11057	13	20	(	(	PUNCT
aiua-11057	13	21	paln	paln	NOUN
aiua-11057	13	22	)	)	PUNCT
aiua-11057	13	23	.	.	PUNCT
aiua-11057	14	1	the	the	DET
aiua-11057	14	2	field	field	NOUN
aiua-11057	14	3	extended	extend	VERB
aiua-11057	14	4	from	from	ADP
aiua-11057	14	5	t11	t11	NOUN
aiua-11057	14	6	/	/	SYM
aiua-11057	14	7	t12	t12	PROPN
aiua-11057	14	8	superiorly	superiorly	ADV
aiua-11057	14	9	till	till	SCONJ
aiua-11057	14	10	l5	l5	PROPN
aiua-11057	14	11	/	/	SYM
aiua-11057	14	12	s1	s1	NOUN
aiua-11057	14	13	inferiorly	inferiorly	ADV
aiua-11057	14	14	using	use	VERB
aiua-11057	14	15	anterior	anterior	ADJ
aiua-11057	14	16	-	-	ADJ
aiua-11057	14	17	posterior	posterior	ADJ
aiua-11057	14	18	-	-	PUNCT
aiua-11057	14	19	posterio	posterio	NOUN
aiua-11057	14	20	-	-	PUNCT
aiua-11057	14	21	anterior	anterior	NOUN
aiua-11057	14	22	(	(	PUNCT
aiua-11057	14	23	ap	ap	PROPN
aiua-11057	14	24	/	/	SYM
aiua-11057	14	25	pa	pa	PROPN
aiua-11057	14	26	)	)	PUNCT
aiua-11057	14	27	field	field	NOUN
aiua-11057	14	28	arrangement	arrangement	NOUN
aiua-11057	14	29	or	or	CCONJ
aiua-11057	14	30	multiple	multiple	ADJ
aiua-11057	14	31	(	(	PUNCT
aiua-11057	14	32	4	4	NUM
aiua-11057	14	33	)	)	PUNCT
aiua-11057	14	34	fields	field	NOUN
aiua-11057	14	35	.	.	PUNCT
aiua-11057	15	1	clinical	clinical	ADJ
aiua-11057	15	2	target	target	NOUN
aiua-11057	15	3	volume	volume	NOUN
aiua-11057	15	4	(	(	PUNCT
aiua-11057	15	5	ctv	ctv	PROPN
aiua-11057	15	6	)	)	PUNCT
aiua-11057	15	7	comprised	comprise	VERB
aiua-11057	15	8	the	the	DET
aiua-11057	15	9	para	para	NOUN
aiua-11057	15	10	-	-	PUNCT
aiua-11057	15	11	caval	caval	NOUN
aiua-11057	15	12	,	,	PUNCT
aiua-11057	15	13	pre	pre	ADJ
aiua-11057	15	14	-	-	ADJ
aiua-11057	15	15	caval	caval	ADJ
aiua-11057	15	16	and	and	CCONJ
aiua-11057	15	17	inter	inter	ADJ
aiua-11057	15	18	aorto	aorto	ADJ
aiua-11057	15	19	-	-	PUNCT
aiua-11057	15	20	caval	caval	ADJ
aiua-11057	15	21	nodes	node	NOUN
aiua-11057	15	22	.	.	PUNCT
aiua-11057	16	1	the	the	DET
aiua-11057	16	2	prescribed	prescribed	ADJ
aiua-11057	16	3	dose	dose	NOUN
aiua-11057	16	4	was	be	AUX
aiua-11057	16	5	(	(	PUNCT
aiua-11057	16	6	25.5gy/1.5gy/17	25.5gy/1.5gy/17	NUM
aiua-11057	16	7	fraction	fraction	NOUN
aiua-11057	16	8	)	)	PUNCT
aiua-11057	16	9	or	or	CCONJ
aiua-11057	16	10	(	(	PUNCT
aiua-11057	16	11	19.8gy/1.8gy/11	19.8gy/1.8gy/11	NUM
aiua-11057	16	12	fraction	fraction	NOUN
aiua-11057	16	13	)	)	PUNCT
aiua-11057	16	14	.	.	PUNCT
aiua-11057	17	1	following	follow	VERB
aiua-11057	17	2	the	the	DET
aiua-11057	17	3	end	end	NOUN
aiua-11057	17	4	of	of	ADP
aiua-11057	17	5	the	the	DET
aiua-11057	17	6	course	course	NOUN
aiua-11057	17	7	,	,	PUNCT
aiua-11057	17	8	follow	follow	VERB
aiua-11057	17	9	up	up	ADP
aiua-11057	17	10	was	be	AUX
aiua-11057	17	11	every	every	DET
aiua-11057	17	12	6	6	NUM
aiua-11057	17	13	months	month	NOUN
aiua-11057	17	14	in	in	ADP
aiua-11057	17	15	the	the	DET
aiua-11057	17	16	first	first	ADJ
aiua-11057	17	17	and	and	CCONJ
aiua-11057	17	18	second	second	ADJ
aiua-11057	17	19	year	year	NOUN
aiua-11057	17	20	then	then	ADV
aiua-11057	17	21	kept	keep	VERB
aiua-11057	17	22	annually	annually	ADV
aiua-11057	17	23	.	.	PUNCT
aiua-11057	18	1	background	background	NOUN
aiua-11057	18	2	:	:	PUNCT
aiua-11057	18	3	the	the	DET
aiua-11057	18	4	mainstay	mainstay	NOUN
aiua-11057	18	5	for	for	ADP
aiua-11057	18	6	management	management	NOUN
aiua-11057	18	7	of	of	ADP
aiua-11057	18	8	stage	stage	NOUN
aiua-11057	18	9	i	i	PRON
aiua-11057	18	10	seminoma	seminoma	VERB
aiua-11057	18	11	is	be	AUX
aiua-11057	18	12	high	high	ADJ
aiua-11057	18	13	inguinal	inguinal	ADJ
aiua-11057	18	14	orchiectomy	orchiectomy	NOUN
aiua-11057	18	15	with	with	ADP
aiua-11057	18	16	post	post	ADJ
aiua-11057	18	17	-	-	ADJ
aiua-11057	18	18	orchiectomy	orchiectomy	ADJ
aiua-11057	18	19	therapeutic	therapeutic	ADJ
aiua-11057	18	20	options	option	NOUN
aiua-11057	18	21	including	include	VERB
aiua-11057	18	22	active	active	ADJ
aiua-11057	18	23	surveillance	surveillance	NOUN
aiua-11057	18	24	,	,	PUNCT
aiua-11057	18	25	chemotherapy	chemotherapy	NOUN
aiua-11057	18	26	or	or	CCONJ
aiua-11057	18	27	radiation	radiation	NOUN
aiua-11057	18	28	therapy	therapy	NOUN
aiua-11057	18	29	.	.	PUNCT
aiua-11057	19	1	objectives	objective	NOUN
aiua-11057	19	2	:	:	PUNCT
aiua-11057	19	3	to	to	PART
aiua-11057	19	4	analyze	analyze	VERB
aiua-11057	19	5	different	different	ADJ
aiua-11057	19	6	post	post	ADJ
aiua-11057	19	7	-	-	ADJ
aiua-11057	19	8	orchiectomy	orchiectomy	ADJ
aiua-11057	19	9	treatment	treatment	NOUN
aiua-11057	19	10	modalities	modality	NOUN
aiua-11057	19	11	outcomes	outcome	NOUN
aiua-11057	19	12	of	of	ADP
aiua-11057	19	13	stage	stage	NOUN
aiua-11057	19	14	i	i	PRON
aiua-11057	19	15	seminoma	seminoma	VERB
aiua-11057	19	16	patients	patient	NOUN
aiua-11057	19	17	presented	present	VERB
aiua-11057	19	18	to	to	ADP
aiua-11057	19	19	nci	nci	PROPN
aiua-11057	19	20	,	,	PUNCT
aiua-11057	19	21	cairo	cairo	PROPN
aiua-11057	19	22	university	university	PROPN
aiua-11057	19	23	in	in	ADP
aiua-11057	19	24	the	the	DET
aiua-11057	19	25	period	period	NOUN
aiua-11057	19	26	from	from	ADP
aiua-11057	19	27	2005	2005	NUM
aiua-11057	19	28	-	-	SYM
aiua-11057	19	29	2019	2019	NUM
aiua-11057	19	30	.	.	PUNCT
aiua-11057	20	1	patients	patient	NOUN
aiua-11057	20	2	and	and	CCONJ
aiua-11057	20	3	methods	method	NOUN
aiua-11057	20	4	:	:	PUNCT
aiua-11057	20	5	a	a	DET
aiua-11057	20	6	retrospective	retrospective	ADJ
aiua-11057	20	7	review	review	NOUN
aiua-11057	20	8	of	of	ADP
aiua-11057	20	9	all	all	DET
aiua-11057	20	10	patients	patient	NOUN
aiua-11057	20	11	'	'	PART
aiua-11057	20	12	records	record	NOUN
aiua-11057	20	13	with	with	ADP
aiua-11057	20	14	clinical	clinical	ADJ
aiua-11057	20	15	stage	stage	NOUN
aiua-11057	20	16	i	i	PRON
aiua-11057	20	17	seminoma	seminoma	VERB
aiua-11057	20	18	who	who	PRON
aiua-11057	20	19	presented	present	VERB
aiua-11057	20	20	to	to	ADP
aiua-11057	20	21	our	our	PRON
aiua-11057	20	22	institute	institute	NOUN
aiua-11057	20	23	in	in	ADP
aiua-11057	20	24	the	the	DET
aiua-11057	20	25	period	period	NOUN
aiua-11057	20	26	from	from	ADP
aiua-11057	20	27	2005	2005	NUM
aiua-11057	20	28	-	-	SYM
aiua-11057	20	29	2019	2019	NUM
aiua-11057	20	30	was	be	AUX
aiua-11057	20	31	done	do	VERB
aiua-11057	20	32	.	.	PUNCT
aiua-11057	21	1	adjuvant	adjuvant	ADJ
aiua-11057	21	2	treatment	treatment	NOUN
aiua-11057	21	3	details	detail	NOUN
aiua-11057	21	4	were	be	AUX
aiua-11057	21	5	extracted	extract	VERB
aiua-11057	21	6	,	,	PUNCT
aiua-11057	21	7	and	and	CCONJ
aiua-11057	21	8	we	we	PRON
aiua-11057	21	9	compared	compare	VERB
aiua-11057	21	10	overall	overall	ADJ
aiua-11057	21	11	survival	survival	NOUN
aiua-11057	21	12	(	(	PUNCT
aiua-11057	21	13	os	os	NOUN
aiua-11057	21	14	)	)	PUNCT
aiua-11057	21	15	and	and	CCONJ
aiua-11057	21	16	disease	disease	NOUN
aiua-11057	21	17	free	free	ADJ
aiua-11057	21	18	survival	survival	NOUN
aiua-11057	21	19	(	(	PUNCT
aiua-11057	21	20	dfs	dfs	PROPN
aiua-11057	21	21	)	)	PUNCT
aiua-11057	21	22	for	for	ADP
aiua-11057	21	23	different	different	ADJ
aiua-11057	21	24	modalities	modality	NOUN
aiua-11057	21	25	and	and	CCONJ
aiua-11057	21	26	changes	change	NOUN
aiua-11057	21	27	in	in	ADP
aiua-11057	21	28	patterns	pattern	NOUN
aiua-11057	21	29	of	of	ADP
aiua-11057	21	30	care	care	NOUN
aiua-11057	21	31	over	over	ADP
aiua-11057	21	32	this	this	DET
aiua-11057	21	33	period	period	NOUN
aiua-11057	21	34	.	.	PUNCT
aiua-11057	22	1	results	result	NOUN
aiua-11057	22	2	:	:	PUNCT
aiua-11057	22	3	thirty	thirty	NUM
aiua-11057	22	4	-	-	PUNCT
aiua-11057	22	5	five	five	NUM
aiua-11057	22	6	patients	patient	NOUN
aiua-11057	22	7	were	be	AUX
aiua-11057	22	8	identified	identify	VERB
aiua-11057	22	9	with	with	ADP
aiua-11057	22	10	thirty	thirty	NUM
aiua-11057	22	11	three	three	NUM
aiua-11057	22	12	patients	patient	NOUN
aiua-11057	22	13	eligible	eligible	ADJ
aiua-11057	22	14	for	for	ADP
aiua-11057	22	15	analysis	analysis	NOUN
aiua-11057	22	16	.	.	PUNCT
aiua-11057	23	1	median	median	ADJ
aiua-11057	23	2	age	age	NOUN
aiua-11057	23	3	was	be	AUX
aiua-11057	23	4	35	35	NUM
aiua-11057	23	5	years	year	NOUN
aiua-11057	23	6	(	(	PUNCT
aiua-11057	23	7	range	range	NOUN
aiua-11057	23	8	,	,	PUNCT
aiua-11057	23	9	19	19	NUM
aiua-11057	23	10	-	-	SYM
aiua-11057	23	11	52	52	NUM
aiua-11057	23	12	)	)	PUNCT
aiua-11057	23	13	.	.	PUNCT
aiua-11057	24	1	fourteen	fourteen	NUM
aiua-11057	24	2	patients	patient	NOUN
aiua-11057	24	3	were	be	AUX
aiua-11057	24	4	kept	keep	VERB
aiua-11057	24	5	under	under	ADP
aiua-11057	24	6	active	active	ADJ
aiua-11057	24	7	surveillance	surveillance	NOUN
aiua-11057	24	8	,	,	PUNCT
aiua-11057	24	9	eleven	eleven	NUM
aiua-11057	24	10	patients	patient	NOUN
aiua-11057	24	11	received	receive	VERB
aiua-11057	24	12	adjuvant	adjuvant	ADJ
aiua-11057	24	13	carboplatin	carboplatin	NOUN
aiua-11057	24	14	and	and	CCONJ
aiua-11057	24	15	eight	eight	NUM
aiua-11057	24	16	patients	patient	NOUN
aiua-11057	24	17	received	receive	VERB
aiua-11057	24	18	adjuvant	adjuvant	ADJ
aiua-11057	24	19	radiation	radiation	NOUN
aiua-11057	24	20	to	to	ADP
aiua-11057	24	21	para	para	NOUN
aiua-11057	24	22	-	-	PUNCT
aiua-11057	24	23	aortic	aortic	ADJ
aiua-11057	24	24	chain	chain	NOUN
aiua-11057	24	25	.	.	PUNCT
aiua-11057	25	1	five	five	NUM
aiua-11057	25	2	-	-	PUNCT
aiua-11057	25	3	year	year	NOUN
aiua-11057	25	4	os	os	NOUN
aiua-11057	25	5	was	be	AUX
aiua-11057	25	6	100	100	NUM
aiua-11057	25	7	%	%	NOUN
aiua-11057	25	8	for	for	ADP
aiua-11057	25	9	all	all	DET
aiua-11057	25	10	patients	patient	NOUN
aiua-11057	25	11	regardless	regardless	ADV
aiua-11057	25	12	post	post	ADJ
aiua-11057	25	13	-	-	ADJ
aiua-11057	25	14	operative	operative	ADJ
aiua-11057	25	15	approach	approach	NOUN
aiua-11057	25	16	.	.	PUNCT
aiua-11057	26	1	five	five	NUM
aiua-11057	26	2	-	-	PUNCT
aiua-11057	26	3	year	year	NOUN
aiua-11057	26	4	dfs	dfs	NOUN
aiua-11057	26	5	was	be	AUX
aiua-11057	26	6	100	100	NUM
aiua-11057	26	7	%	%	NOUN
aiua-11057	26	8	for	for	ADP
aiua-11057	26	9	patients	patient	NOUN
aiua-11057	26	10	who	who	PRON
aiua-11057	26	11	received	receive	VERB
aiua-11057	26	12	adjuvant	adjuvant	ADJ
aiua-11057	26	13	chemotherapy	chemotherapy	NOUN
aiua-11057	26	14	or	or	CCONJ
aiua-11057	26	15	radiotherapy	radiotherapy	NOUN
aiua-11057	26	16	versus	versus	ADP
aiua-11057	26	17	93	93	NUM
aiua-11057	26	18	%	%	NOUN
aiua-11057	26	19	for	for	ADP
aiua-11057	26	20	patients	patient	NOUN
aiua-11057	26	21	who	who	PRON
aiua-11057	26	22	were	be	AUX
aiua-11057	26	23	kept	keep	VERB
aiua-11057	26	24	under	under	ADP
aiua-11057	26	25	active	active	ADJ
aiua-11057	26	26	surveillance	surveillance	NOUN
aiua-11057	26	27	(	(	PUNCT
aiua-11057	26	28	p	p	X
aiua-11057	26	29	=	=	NOUN
aiua-11057	26	30	0.03	0.03	NUM
aiua-11057	26	31	)	)	PUNCT
aiua-11057	26	32	.	.	PUNCT
aiua-11057	27	1	conclusions	conclusion	NOUN
aiua-11057	27	2	:	:	PUNCT
aiua-11057	27	3	clinical	clinical	ADJ
aiua-11057	27	4	stage	stage	NOUN
aiua-11057	27	5	i	i	PRON
aiua-11057	27	6	seminoma	seminoma	VERB
aiua-11057	27	7	is	be	AUX
aiua-11057	27	8	a	a	DET
aiua-11057	27	9	favorable	favorable	ADJ
aiua-11057	27	10	disease	disease	NOUN
aiua-11057	27	11	entity	entity	NOUN
aiua-11057	27	12	with	with	ADP
aiua-11057	27	13	favorable	favorable	ADJ
aiua-11057	27	14	disease	disease	NOUN
aiua-11057	27	15	related	relate	VERB
aiua-11057	27	16	outcomes	outcome	NOUN
aiua-11057	27	17	regardless	regardless	ADV
aiua-11057	27	18	postoperative	postoperative	ADJ
aiua-11057	27	19	approach	approach	NOUN
aiua-11057	27	20	.	.	PUNCT
aiua-11057	28	1	active	active	ADJ
aiua-11057	28	2	surveillance	surveillance	NOUN
aiua-11057	28	3	is	be	AUX
aiua-11057	28	4	reasonable	reasonable	ADJ
aiua-11057	28	5	and	and	CCONJ
aiua-11057	28	6	safe	safe	ADJ
aiua-11057	28	7	given	give	VERB
aiua-11057	28	8	equal	equal	ADJ
aiua-11057	28	9	survival	survival	NOUN
aiua-11057	28	10	to	to	ADP
aiua-11057	28	11	active	active	ADJ
aiua-11057	28	12	treatment	treatment	NOUN
aiua-11057	28	13	.	.	PUNCT
aiua-11057	29	1	key	key	ADJ
aiua-11057	29	2	words	word	NOUN
aiua-11057	29	3	:	:	PUNCT
aiua-11057	29	4	seminoma	seminoma	NOUN
aiua-11057	29	5	;	;	PUNCT
aiua-11057	29	6	stage	stage	NOUN
aiua-11057	29	7	i	i	PRON
aiua-11057	29	8	;	;	PUNCT
aiua-11057	29	9	surveillance	surveillance	NOUN
aiua-11057	29	10	;	;	PUNCT
aiua-11057	29	11	radiotherapy	radiotherapy	NOUN
aiua-11057	29	12	;	;	PUNCT
aiua-11057	29	13	chemotherapy	chemotherapy	NOUN
aiua-11057	29	14	.	.	PUNCT
aiua-11057	29	15	submitted	submit	VERB
aiua-11057	29	16	18	18	NUM
aiua-11057	29	17	december	december	PROPN
aiua-11057	29	18	2022	2022	NUM
aiua-11057	29	19	;	;	PUNCT
aiua-11057	29	20	accepted	accept	VERB
aiua-11057	29	21	31	31	NUM
aiua-11057	29	22	december	december	PROPN
aiua-11057	29	23	2022	2022	NUM
aiua-11057	29	24	introduction	introduction	NOUN
aiua-11057	29	25	testicular	testicular	ADJ
aiua-11057	29	26	cancers	cancer	NOUN
aiua-11057	29	27	are	be	AUX
aiua-11057	29	28	rare	rare	ADJ
aiua-11057	29	29	tumors	tumor	NOUN
aiua-11057	29	30	with	with	ADP
aiua-11057	29	31	an	an	DET
aiua-11057	29	32	incidence	incidence	NOUN
aiua-11057	29	33	of	of	ADP
aiua-11057	29	34	less	less	ADJ
aiua-11057	29	35	than	than	ADP
aiua-11057	29	36	1	1	NUM
aiua-11057	29	37	%	%	NOUN
aiua-11057	29	38	of	of	ADP
aiua-11057	29	39	all	all	DET
aiua-11057	29	40	male	male	ADJ
aiua-11057	29	41	tumors	tumor	NOUN
aiua-11057	29	42	(	(	PUNCT
aiua-11057	29	43	1	1	NUM
aiua-11057	29	44	)	)	PUNCT
aiua-11057	29	45	.	.	PUNCT
aiua-11057	30	1	the	the	DET
aiua-11057	30	2	standard	standard	ADJ
aiua-11057	30	3	management	management	NOUN
aiua-11057	30	4	of	of	ADP
aiua-11057	30	5	testicular	testicular	ADJ
aiua-11057	30	6	tumors	tumor	NOUN
aiua-11057	30	7	starts	start	VERB
aiua-11057	30	8	with	with	ADP
aiua-11057	30	9	high	high	ADJ
aiua-11057	30	10	inguinal	inguinal	ADJ
aiua-11057	30	11	orchiectomy	orchiectomy	NOUN
aiua-11057	30	12	followed	follow	VERB
aiua-11057	30	13	by	by	ADP
aiua-11057	30	14	a	a	DET
aiua-11057	30	15	stage	stage	NOUN
aiua-11057	30	16	and	and	CCONJ
aiua-11057	30	17	pathology	pathology	NOUN
aiua-11057	30	18	dictated	dictate	VERB
aiua-11057	30	19	management	management	NOUN
aiua-11057	30	20	(	(	PUNCT
aiua-11057	30	21	2	2	NUM
aiua-11057	30	22	)	)	PUNCT
aiua-11057	30	23	.	.	PUNCT
aiua-11057	31	1	clinical	clinical	ADJ
aiua-11057	31	2	stage	stage	NOUN
aiua-11057	31	3	i	i	PRON
aiua-11057	31	4	seminoma	seminoma	VERB
aiua-11057	31	5	has	have	VERB
aiua-11057	31	6	a	a	DET
aiua-11057	31	7	very	very	ADV
aiua-11057	31	8	favorable	favorable	ADJ
aiua-11057	31	9	outcome	outcome	NOUN
aiua-11057	31	10	after	after	ADP
aiua-11057	31	11	surgery	surgery	NOUN
aiua-11057	31	12	(	(	PUNCT
aiua-11057	31	13	3	3	NUM
aiua-11057	31	14	)	)	PUNCT
aiua-11057	31	15	.	.	PUNCT
aiua-11057	32	1	management	management	NOUN
aiua-11057	32	2	options	option	NOUN
aiua-11057	32	3	for	for	ADP
aiua-11057	32	4	stage	stage	NOUN
aiua-11057	32	5	i	i	PRON
aiua-11057	32	6	disease	disease	NOUN
aiua-11057	32	7	have	have	AUX
aiua-11057	32	8	evolved	evolve	VERB
aiua-11057	32	9	over	over	ADP
aiua-11057	32	10	the	the	DET
aiua-11057	32	11	past	past	ADJ
aiua-11057	32	12	decades	decade	NOUN
aiua-11057	32	13	from	from	ADP
aiua-11057	32	14	adjuvant	adjuvant	ADJ
aiua-11057	32	15	radiation	radiation	NOUN
aiua-11057	32	16	to	to	ADP
aiua-11057	32	17	para	para	NOUN
aiua-11057	32	18	-	-	PUNCT
aiua-11057	32	19	aortic	aortic	ADJ
aiua-11057	32	20	chain	chain	NOUN
aiua-11057	32	21	to	to	ADP
aiua-11057	32	22	chemotherapy	chemotherapy	NOUN
aiua-11057	32	23	with	with	ADP
aiua-11057	32	24	single	single	ADJ
aiua-11057	32	25	agent	agent	NOUN
aiua-11057	32	26	carboplatin	carboplatin	NOUN
aiua-11057	32	27	and	and	CCONJ
aiua-11057	32	28	finally	finally	ADV
aiua-11057	32	29	moving	move	VERB
aiua-11057	32	30	to	to	ADP
aiua-11057	32	31	active	active	ADJ
aiua-11057	32	32	surveillance	surveillance	NOUN
aiua-11057	32	33	with	with	ADP
aiua-11057	32	34	equal	equal	ADJ
aiua-11057	32	35	survival	survival	NOUN
aiua-11057	32	36	among	among	ADP
aiua-11057	32	37	all	all	DET
aiua-11057	32	38	strategies	strategy	NOUN
aiua-11057	32	39	(	(	PUNCT
aiua-11057	32	40	4	4	NUM
aiua-11057	32	41	)	)	PUNCT
aiua-11057	32	42	.	.	PUNCT
aiua-11057	33	1	herein	herein	NOUN
aiua-11057	33	2	,	,	PUNCT
aiua-11057	33	3	we	we	PRON
aiua-11057	33	4	review	review	VERB
aiua-11057	33	5	our	our	PRON
aiua-11057	33	6	experience	experience	NOUN
aiua-11057	33	7	and	and	CCONJ
aiua-11057	33	8	changes	change	NOUN
aiua-11057	33	9	in	in	ADP
aiua-11057	33	10	patterns	pattern	NOUN
aiua-11057	33	11	of	of	ADP
aiua-11057	33	12	care	care	NOUN
aiua-11057	33	13	over	over	ADP
aiua-11057	33	14	time	time	NOUN
aiua-11057	33	15	.	.	PUNCT
aiua-11057	34	1	stage	stage	NOUN
aiua-11057	34	2	i	i	PRON
aiua-11057	34	3	seminoma	seminoma	VERB
aiua-11057	34	4	:	:	PUNCT
aiua-11057	34	5	outcome	outcome	NOUN
aiua-11057	34	6	of	of	ADP
aiua-11057	34	7	different	different	ADJ
aiua-11057	34	8	treatment	treatment	NOUN
aiua-11057	34	9	modalities	modality	NOUN
aiua-11057	34	10	and	and	CCONJ
aiua-11057	34	11	changes	change	NOUN
aiua-11057	34	12	in	in	ADP
aiua-11057	34	13	patterns	pattern	NOUN
aiua-11057	34	14	of	of	ADP
aiua-11057	34	15	care	care	NOUN
aiua-11057	34	16	.	.	PUNCT
aiua-11057	35	1	a	a	DET
aiua-11057	35	2	single	single	ADJ
aiua-11057	35	3	institution	institution	NOUN
aiua-11057	35	4	experience	experience	NOUN
aiua-11057	35	5	manar	manar	PROPN
aiua-11057	35	6	mahmoud	mahmoud	PROPN
aiua-11057	35	7	sayed	say	VERB
aiua-11057	35	8	1	1	NUM
aiua-11057	35	9	,	,	PUNCT
aiua-11057	35	10	azza	azza	PROPN
aiua-11057	35	11	mohamad	mohamad	PROPN
aiua-11057	35	12	nasr	nasr	PROPN
aiua-11057	35	13	1	1	NUM
aiua-11057	35	14	,	,	PUNCT
aiua-11057	35	15	ibtesam	ibtesam	PROPN
aiua-11057	35	16	mohamad	mohamad	PROPN
aiua-11057	35	17	saad	saad	PROPN
aiua-11057	35	18	eldin	eldin	PROPN
aiua-11057	35	19	2	2	NUM
aiua-11057	35	20	,	,	PUNCT
aiua-11057	35	21	yasser	yasser	PROPN
aiua-11057	35	22	anwar	anwar	PROPN
aiua-11057	35	23	abdelazim	abdelazim	VERB
aiua-11057	35	24	1	1	NUM
aiua-11057	35	25	1	1	NUM
aiua-11057	35	26	department	department	NOUN
aiua-11057	35	27	of	of	ADP
aiua-11057	35	28	radiation	radiation	NOUN
aiua-11057	35	29	oncology	oncology	NOUN
aiua-11057	35	30	,	,	PUNCT
aiua-11057	35	31	national	national	PROPN
aiua-11057	35	32	cancer	cancer	PROPN
aiua-11057	35	33	institute	institute	PROPN
aiua-11057	35	34	,	,	PUNCT
aiua-11057	35	35	cairo	cairo	PROPN
aiua-11057	35	36	university	university	PROPN
aiua-11057	35	37	,	,	PUNCT
aiua-11057	35	38	egypt	egypt	PROPN
aiua-11057	35	39	;	;	PUNCT
aiua-11057	35	40	2	2	NUM
aiua-11057	35	41	department	department	NOUN
aiua-11057	35	42	of	of	ADP
aiua-11057	35	43	clinical	clinical	ADJ
aiua-11057	35	44	oncology	oncology	NOUN
aiua-11057	35	45	,	,	PUNCT
aiua-11057	35	46	faculty	faculty	NOUN
aiua-11057	35	47	of	of	ADP
aiua-11057	35	48	medicine	medicine	NOUN
aiua-11057	35	49	,	,	PUNCT
aiua-11057	35	50	cairo	cairo	PROPN
aiua-11057	35	51	university	university	PROPN
aiua-11057	35	52	,	,	PUNCT
aiua-11057	35	53	egypt	egypt	PROPN
aiua-11057	35	54	.	.	PUNCT
aiua-11057	36	1	doi	doi	PROPN
aiua-11057	36	2	:	:	PUNCT
aiua-11057	36	3	10.4081	10.4081	NUM
aiua-11057	36	4	/	/	SYM
aiua-11057	36	5	aiua.2023.11057	aiua.2023.11057	NOUN
aiua-11057	36	6	summary	summary	NOUN
aiua-11057	36	7	archivio	archivio	NOUN
aiua-11057	36	8	italiano	italiano	X
aiua-11057	36	9	di	di	X
aiua-11057	36	10	urologia	urologia	PROPN
aiua-11057	36	11	e	e	PROPN
aiua-11057	36	12	andrologia	andrologia	NOUN
aiua-11057	36	13	2023	2023	NUM
aiua-11057	36	14	;	;	PUNCT
aiua-11057	36	15	95	95	NUM
aiua-11057	36	16	,	,	PUNCT
aiua-11057	36	17	1	1	NUM
aiua-11057	36	18	m.	m.	NOUN
aiua-11057	36	19	mahmoud	mahmoud	PROPN
aiua-11057	36	20	sayed	sayed	PROPN
aiua-11057	36	21	,	,	PUNCT
aiua-11057	36	22	a.	a.	PROPN
aiua-11057	36	23	mohamad	mohamad	PROPN
aiua-11057	36	24	nasr	nasr	PROPN
aiua-11057	36	25	,	,	PUNCT
aiua-11057	36	26	i.	i.	PROPN
aiua-11057	36	27	mohamad	mohamad	PROPN
aiua-11057	36	28	saad	saad	PROPN
aiua-11057	36	29	eldin	eldin	PROPN
aiua-11057	36	30	,	,	PUNCT
aiua-11057	36	31	y.	y.	PROPN
aiua-11057	36	32	anwar	anwar	PROPN
aiua-11057	36	33	abdelazim	abdelazim	PROPN
aiua-11057	36	34	statistical	statistical	ADJ
aiua-11057	36	35	methodology	methodology	NOUN
aiua-11057	36	36	data	datum	NOUN
aiua-11057	36	37	management	management	NOUN
aiua-11057	36	38	and	and	CCONJ
aiua-11057	36	39	analysis	analysis	NOUN
aiua-11057	36	40	was	be	AUX
aiua-11057	36	41	performed	perform	VERB
aiua-11057	36	42	using	use	VERB
aiua-11057	36	43	statistical	statistical	ADJ
aiua-11057	36	44	package	package	NOUN
aiua-11057	36	45	for	for	ADP
aiua-11057	36	46	social	social	ADJ
aiua-11057	36	47	sciences	science	NOUN
aiua-11057	36	48	(	(	PUNCT
aiua-11057	36	49	spss	spss	PROPN
aiua-11057	36	50	)	)	PUNCT
aiua-11057	36	51	vs.	vs.	ADP
aiua-11057	36	52	25	25	NUM
aiua-11057	36	53	.	.	PUNCT
aiua-11057	37	1	numerical	numerical	PROPN
aiua-11057	37	2	data	data	PROPN
aiua-11057	37	3	were	be	AUX
aiua-11057	37	4	checked	check	VERB
aiua-11057	37	5	for	for	ADP
aiua-11057	37	6	normality	normality	NOUN
aiua-11057	37	7	and	and	CCONJ
aiua-11057	37	8	were	be	AUX
aiua-11057	37	9	statistically	statistically	ADV
aiua-11057	37	10	described	describe	VERB
aiua-11057	37	11	as	as	ADP
aiua-11057	37	12	means	mean	NOUN
aiua-11057	37	13	(	(	PUNCT
aiua-11057	37	14	standard	standard	ADJ
aiua-11057	37	15	deviations	deviation	NOUN
aiua-11057	37	16	)	)	PUNCT
aiua-11057	37	17	or	or	CCONJ
aiua-11057	37	18	medians	median	NOUN
aiua-11057	37	19	(	(	PUNCT
aiua-11057	37	20	ranges	range	NOUN
aiua-11057	37	21	)	)	PUNCT
aiua-11057	37	22	as	as	ADP
aiua-11057	37	23	appropriate	appropriate	ADJ
aiua-11057	37	24	.	.	PUNCT
aiua-11057	38	1	categorical	categorical	ADJ
aiua-11057	38	2	data	datum	NOUN
aiua-11057	38	3	were	be	AUX
aiua-11057	38	4	described	describe	VERB
aiua-11057	38	5	as	as	ADP
aiua-11057	38	6	numbers	number	NOUN
aiua-11057	38	7	and	and	CCONJ
aiua-11057	38	8	percentages	percentage	NOUN
aiua-11057	38	9	.	.	PUNCT
aiua-11057	39	1	survival	survival	NOUN
aiua-11057	39	2	analysis	analysis	NOUN
aiua-11057	39	3	was	be	AUX
aiua-11057	39	4	done	do	VERB
aiua-11057	39	5	using	use	VERB
aiua-11057	39	6	kaplan	kaplan	PROPN
aiua-11057	39	7	-	-	PUNCT
aiua-11057	39	8	meier	meier	PROPN
aiua-11057	39	9	method	method	NOUN
aiua-11057	39	10	with	with	ADP
aiua-11057	39	11	comparison	comparison	NOUN
aiua-11057	39	12	between	between	ADP
aiua-11057	39	13	two	two	NUM
aiua-11057	39	14	or	or	CCONJ
aiua-11057	39	15	more	more	ADJ
aiua-11057	39	16	survival	survival	NOUN
aiua-11057	39	17	curves	curve	NOUN
aiua-11057	39	18	using	use	VERB
aiua-11057	39	19	log	log	NOUN
aiua-11057	39	20	rank	rank	NOUN
aiua-11057	39	21	test	test	NOUN
aiua-11057	39	22	with	with	ADP
aiua-11057	39	23	bonferroni	bonferroni	NOUN
aiua-11057	39	24	adjustment	adjustment	NOUN
aiua-11057	39	25	when	when	SCONJ
aiua-11057	39	26	necessary	necessary	ADJ
aiua-11057	39	27	.	.	PUNCT
aiua-11057	40	1	all	all	DET
aiua-11057	40	2	statistically	statistically	ADV
aiua-11057	40	3	significant	significant	ADJ
aiua-11057	40	4	factors	factor	NOUN
aiua-11057	40	5	on	on	ADP
aiua-11057	40	6	kaplan	kaplan	PROPN
aiua-11057	40	7	-	-	PUNCT
aiua-11057	40	8	meier	meier	PROPN
aiua-11057	40	9	analysis	analysis	NOUN
aiua-11057	40	10	entered	enter	VERB
aiua-11057	40	11	the	the	DET
aiua-11057	40	12	multivariate	multivariate	NOUN
aiua-11057	40	13	cox	cox	PROPN
aiua-11057	40	14	regression	regression	VERB
aiua-11057	40	15	analysis	analysis	NOUN
aiua-11057	40	16	using	use	VERB
aiua-11057	40	17	forward	forward	ADV
aiua-11057	40	18	likelihood	likelihood	NOUN
aiua-11057	40	19	-	-	PUNCT
aiua-11057	40	20	ratio	ratio	NOUN
aiua-11057	40	21	(	(	PUNCT
aiua-11057	40	22	lr	lr	NOUN
aiua-11057	40	23	)	)	PUNCT
aiua-11057	40	24	method	method	NOUN
aiua-11057	40	25	for	for	ADP
aiua-11057	40	26	variable	variable	ADJ
aiua-11057	40	27	selection	selection	NOUN
aiua-11057	40	28	.	.	PUNCT
aiua-11057	41	1	hazard	hazard	NOUN
aiua-11057	41	2	ratios	ratio	NOUN
aiua-11057	41	3	were	be	AUX
aiua-11057	41	4	computed	compute	VERB
aiua-11057	41	5	for	for	ADP
aiua-11057	41	6	significant	significant	ADJ
aiua-11057	41	7	factors	factor	NOUN
aiua-11057	41	8	in	in	ADP
aiua-11057	41	9	the	the	DET
aiua-11057	41	10	last	last	ADJ
aiua-11057	41	11	step	step	NOUN
aiua-11057	41	12	of	of	ADP
aiua-11057	41	13	cox	cox	PROPN
aiua-11057	41	14	-	-	PUNCT
aiua-11057	41	15	regression	regression	NOUN
aiua-11057	41	16	with	with	ADP
aiua-11057	41	17	95	95	NUM
aiua-11057	41	18	%	%	NOUN
aiua-11057	41	19	confidence	confidence	NOUN
aiua-11057	41	20	interval	interval	NOUN
aiua-11057	41	21	estimates	estimate	NOUN
aiua-11057	41	22	.	.	PUNCT
aiua-11057	42	1	all	all	DET
aiua-11057	42	2	tests	test	NOUN
aiua-11057	42	3	were	be	AUX
aiua-11057	42	4	2	2	NUM
aiua-11057	42	5	tailed	tailed	ADJ
aiua-11057	42	6	and	and	CCONJ
aiua-11057	42	7	p	p	NOUN
aiua-11057	42	8	-	-	PUNCT
aiua-11057	42	9	value	value	NOUN
aiua-11057	42	10	<	<	X
aiua-11057	42	11	0.05	0.05	NUM
aiua-11057	42	12	was	be	AUX
aiua-11057	42	13	considered	consider	VERB
aiua-11057	42	14	statistically	statistically	ADV
aiua-11057	42	15	significant	significant	ADJ
aiua-11057	42	16	.	.	PUNCT
aiua-11057	43	1	all	all	DET
aiua-11057	43	2	the	the	DET
aiua-11057	43	3	patients	patient	NOUN
aiua-11057	43	4	treated	treat	VERB
aiua-11057	43	5	with	with	ADP
aiua-11057	43	6	different	different	ADJ
aiua-11057	43	7	modalities	modality	NOUN
aiua-11057	43	8	were	be	AUX
aiua-11057	43	9	compared	compare	VERB
aiua-11057	43	10	in	in	ADP
aiua-11057	43	11	terms	term	NOUN
aiua-11057	43	12	of	of	ADP
aiua-11057	43	13	overall	overall	ADJ
aiua-11057	43	14	survival	survival	NOUN
aiua-11057	43	15	(	(	PUNCT
aiua-11057	43	16	os	os	NOUN
aiua-11057	43	17	)	)	PUNCT
aiua-11057	43	18	,	,	PUNCT
aiua-11057	43	19	disease	disease	NOUN
aiua-11057	43	20	-	-	PUNCT
aiua-11057	43	21	free	free	ADJ
aiua-11057	43	22	survival	survival	NOUN
aiua-11057	43	23	(	(	PUNCT
aiua-11057	43	24	dfs	dfs	PROPN
aiua-11057	43	25	)	)	PUNCT
aiua-11057	43	26	,	,	PUNCT
aiua-11057	43	27	loco	loco	PROPN
aiua-11057	43	28	-	-	PUNCT
aiua-11057	43	29	regional	regional	ADJ
aiua-11057	43	30	control	control	NOUN
aiua-11057	43	31	(	(	PUNCT
aiua-11057	43	32	lrc	lrc	PROPN
aiua-11057	43	33	)	)	PUNCT
aiua-11057	43	34	and	and	CCONJ
aiua-11057	43	35	metastaticfree	metastaticfree	ADJ
aiua-11057	43	36	survival	survival	NOUN
aiua-11057	43	37	(	(	PUNCT
aiua-11057	43	38	mfs	mfs	PROPN
aiua-11057	43	39	)	)	PUNCT
aiua-11057	43	40	.	.	PUNCT
aiua-11057	44	1	os	os	PROPN
aiua-11057	44	2	was	be	AUX
aiua-11057	44	3	calculated	calculate	VERB
aiua-11057	44	4	from	from	ADP
aiua-11057	44	5	the	the	DET
aiua-11057	44	6	date	date	NOUN
aiua-11057	44	7	of	of	ADP
aiua-11057	44	8	diagnosis	diagnosis	NOUN
aiua-11057	44	9	to	to	ADP
aiua-11057	44	10	the	the	DET
aiua-11057	44	11	date	date	NOUN
aiua-11057	44	12	of	of	ADP
aiua-11057	44	13	death	death	NOUN
aiua-11057	44	14	or	or	CCONJ
aiua-11057	44	15	last	last	ADJ
aiua-11057	44	16	follow	follow	NOUN
aiua-11057	44	17	-	-	PUNCT
aiua-11057	44	18	up	up	NOUN
aiua-11057	44	19	,	,	PUNCT
aiua-11057	44	20	disease	disease	NOUN
aiua-11057	44	21	free	free	ADJ
aiua-11057	44	22	survival	survival	NOUN
aiua-11057	44	23	(	(	PUNCT
aiua-11057	44	24	dfs	dfs	PROPN
aiua-11057	44	25	)	)	PUNCT
aiua-11057	44	26	was	be	AUX
aiua-11057	44	27	calculated	calculate	VERB
aiua-11057	44	28	from	from	ADP
aiua-11057	44	29	the	the	DET
aiua-11057	44	30	date	date	NOUN
aiua-11057	44	31	of	of	ADP
aiua-11057	44	32	surgery	surgery	NOUN
aiua-11057	44	33	to	to	ADP
aiua-11057	44	34	the	the	DET
aiua-11057	44	35	date	date	NOUN
aiua-11057	44	36	of	of	ADP
aiua-11057	44	37	locoregional	locoregional	ADJ
aiua-11057	44	38	recurrence	recurrence	NOUN
aiua-11057	44	39	or	or	CCONJ
aiua-11057	44	40	metastasis	metastasis	NOUN
aiua-11057	44	41	whichever	whichever	PRON
aiua-11057	44	42	comes	come	VERB
aiua-11057	44	43	first	first	ADV
aiua-11057	44	44	.	.	PUNCT
aiua-11057	45	1	metastasis	metastasis	PRON
aiua-11057	45	2	free	free	ADJ
aiua-11057	45	3	survival	survival	NOUN
aiua-11057	45	4	(	(	PUNCT
aiua-11057	45	5	mfs	mfs	PROPN
aiua-11057	45	6	)	)	PUNCT
aiua-11057	45	7	was	be	AUX
aiua-11057	45	8	calculated	calculate	VERB
aiua-11057	45	9	from	from	ADP
aiua-11057	45	10	the	the	DET
aiua-11057	45	11	date	date	NOUN
aiua-11057	45	12	of	of	ADP
aiua-11057	45	13	surgery	surgery	NOUN
aiua-11057	45	14	to	to	ADP
aiua-11057	45	15	the	the	DET
aiua-11057	45	16	date	date	NOUN
aiua-11057	45	17	of	of	ADP
aiua-11057	45	18	metastasis	metastasis	NOUN
aiua-11057	45	19	.	.	PUNCT
aiua-11057	46	1	para	para	NOUN
aiua-11057	46	2	-	-	PUNCT
aiua-11057	46	3	aortic	aortic	ADJ
aiua-11057	46	4	nodal	nodal	NOUN
aiua-11057	46	5	relapse	relapse	NOUN
aiua-11057	46	6	was	be	AUX
aiua-11057	46	7	not	not	PART
aiua-11057	46	8	considered	consider	VERB
aiua-11057	46	9	as	as	ADP
aiua-11057	46	10	metastatic	metastatic	ADJ
aiua-11057	46	11	event	event	NOUN
aiua-11057	46	12	but	but	CCONJ
aiua-11057	46	13	a	a	DET
aiua-11057	46	14	loco	loco	NOUN
aiua-11057	46	15	-	-	PUNCT
aiua-11057	46	16	regional	regional	ADJ
aiua-11057	46	17	failure	failure	NOUN
aiua-11057	46	18	.	.	PUNCT
aiua-11057	47	1	time	time	NOUN
aiua-11057	47	2	to	to	ADP
aiua-11057	47	3	loco	loco	PROPN
aiua-11057	47	4	-	-	PUNCT
aiua-11057	47	5	regional	regional	ADJ
aiua-11057	47	6	control	control	NOUN
aiua-11057	47	7	(	(	PUNCT
aiua-11057	47	8	lrc	lrc	PROPN
aiua-11057	47	9	)	)	PUNCT
aiua-11057	47	10	was	be	AUX
aiua-11057	47	11	calculated	calculate	VERB
aiua-11057	47	12	from	from	ADP
aiua-11057	47	13	the	the	DET
aiua-11057	47	14	date	date	NOUN
aiua-11057	47	15	of	of	ADP
aiua-11057	47	16	surgery	surgery	NOUN
aiua-11057	47	17	to	to	ADP
aiua-11057	47	18	the	the	DET
aiua-11057	47	19	date	date	NOUN
aiua-11057	47	20	of	of	ADP
aiua-11057	47	21	loco	loco	PROPN
aiua-11057	47	22	-	-	PUNCT
aiua-11057	47	23	regional	regional	ADJ
aiua-11057	47	24	recurrence	recurrence	NOUN
aiua-11057	47	25	.	.	PUNCT
aiua-11057	48	1	results	result	NOUN
aiua-11057	48	2	in	in	ADP
aiua-11057	48	3	the	the	DET
aiua-11057	48	4	period	period	NOUN
aiua-11057	48	5	from	from	ADP
aiua-11057	48	6	2005	2005	NUM
aiua-11057	48	7	to	to	ADP
aiua-11057	48	8	2019	2019	NUM
aiua-11057	48	9	,	,	PUNCT
aiua-11057	48	10	thirty	thirty	NUM
aiua-11057	48	11	five	five	NUM
aiua-11057	48	12	patients	patient	NOUN
aiua-11057	48	13	with	with	ADP
aiua-11057	48	14	clinical	clinical	ADJ
aiua-11057	48	15	stage	stage	NOUN
aiua-11057	48	16	i	i	PRON
aiua-11057	48	17	seminoma	seminoma	VERB
aiua-11057	48	18	presented	present	VERB
aiua-11057	48	19	to	to	ADP
aiua-11057	48	20	national	national	PROPN
aiua-11057	48	21	cancer	cancer	PROPN
aiua-11057	48	22	institute	institute	PROPN
aiua-11057	48	23	,	,	PUNCT
aiua-11057	48	24	cairo	cairo	PROPN
aiua-11057	48	25	university	university	PROPN
aiua-11057	48	26	.	.	PUNCT
aiua-11057	49	1	thirty	thirty	NUM
aiua-11057	49	2	three	three	NUM
aiua-11057	49	3	patients	patient	NOUN
aiua-11057	49	4	were	be	AUX
aiua-11057	49	5	included	include	VERB
aiua-11057	49	6	in	in	ADP
aiua-11057	49	7	our	our	PRON
aiua-11057	49	8	analysis	analysis	NOUN
aiua-11057	49	9	and	and	CCONJ
aiua-11057	49	10	two	two	NUM
aiua-11057	49	11	patients	patient	NOUN
aiua-11057	49	12	were	be	AUX
aiua-11057	49	13	excluded	exclude	VERB
aiua-11057	49	14	from	from	ADP
aiua-11057	49	15	survival	survival	NOUN
aiua-11057	49	16	analysis	analysis	NOUN
aiua-11057	49	17	due	due	ADJ
aiua-11057	49	18	to	to	ADP
aiua-11057	49	19	lost	lose	VERB
aiua-11057	49	20	follow	follow	VERB
aiua-11057	49	21	up	up	ADP
aiua-11057	49	22	.	.	PUNCT
aiua-11057	50	1	median	median	ADJ
aiua-11057	50	2	age	age	NOUN
aiua-11057	50	3	in	in	ADP
aiua-11057	50	4	our	our	PRON
aiua-11057	50	5	cohort	cohort	NOUN
aiua-11057	50	6	was	be	AUX
aiua-11057	50	7	35	35	NUM
aiua-11057	50	8	years	year	NOUN
aiua-11057	50	9	(	(	PUNCT
aiua-11057	50	10	range	range	NOUN
aiua-11057	50	11	,	,	PUNCT
aiua-11057	50	12	19	19	NUM
aiua-11057	50	13	-	-	SYM
aiua-11057	50	14	52	52	NUM
aiua-11057	50	15	)	)	PUNCT
aiua-11057	50	16	.	.	PUNCT
aiua-11057	51	1	thirty	thirty	NUM
aiua-11057	51	2	two	two	NUM
aiua-11057	51	3	patients	patient	NOUN
aiua-11057	51	4	(	(	PUNCT
aiua-11057	51	5	91	91	NUM
aiua-11057	51	6	%	%	NOUN
aiua-11057	51	7	)	)	PUNCT
aiua-11057	51	8	had	have	VERB
aiua-11057	51	9	classic	classic	ADJ
aiua-11057	51	10	subtype	subtype	NOUN
aiua-11057	51	11	and	and	CCONJ
aiua-11057	51	12	three	three	NUM
aiua-11057	51	13	patients	patient	NOUN
aiua-11057	51	14	(	(	PUNCT
aiua-11057	51	15	9	9	NUM
aiua-11057	51	16	%	%	NOUN
aiua-11057	51	17	)	)	PUNCT
aiua-11057	51	18	had	have	VERB
aiua-11057	51	19	spermatocytic	spermatocytic	ADJ
aiua-11057	51	20	subtype	subtype	NOUN
aiua-11057	51	21	.	.	PUNCT
aiua-11057	52	1	patients	patient	NOUN
aiua-11057	52	2	'	'	PART
aiua-11057	52	3	clinical	clinical	ADJ
aiua-11057	52	4	and	and	CCONJ
aiua-11057	52	5	demographic	demographic	ADJ
aiua-11057	52	6	characteristics	characteristic	NOUN
aiua-11057	52	7	are	be	AUX
aiua-11057	52	8	summarized	summarize	VERB
aiua-11057	52	9	in	in	ADP
aiua-11057	52	10	table	table	NOUN
aiua-11057	52	11	1	1	NUM
aiua-11057	52	12	.	.	X
aiua-11057	52	13	fourteen	fourteen	NUM
aiua-11057	52	14	patients	patient	NOUN
aiua-11057	52	15	(	(	PUNCT
aiua-11057	52	16	42	42	NUM
aiua-11057	52	17	%	%	NOUN
aiua-11057	52	18	)	)	PUNCT
aiua-11057	52	19	were	be	AUX
aiua-11057	52	20	kept	keep	VERB
aiua-11057	52	21	under	under	ADP
aiua-11057	52	22	active	active	ADJ
aiua-11057	52	23	surveillance	surveillance	NOUN
aiua-11057	52	24	,	,	PUNCT
aiua-11057	52	25	eight	eight	NUM
aiua-11057	52	26	patients	patient	NOUN
aiua-11057	52	27	(	(	PUNCT
aiua-11057	52	28	24	24	NUM
aiua-11057	52	29	%	%	NOUN
aiua-11057	52	30	)	)	PUNCT
aiua-11057	52	31	received	receive	VERB
aiua-11057	52	32	adjuvant	adjuvant	ADJ
aiua-11057	52	33	radiation	radiation	NOUN
aiua-11057	52	34	therapy	therapy	NOUN
aiua-11057	52	35	to	to	ADP
aiua-11057	52	36	para	para	VERB
aiua-11057	52	37	-	-	PUNCT
aiua-11057	52	38	aortic	aortic	ADJ
aiua-11057	52	39	nodal	nodal	NOUN
aiua-11057	52	40	chain	chain	NOUN
aiua-11057	52	41	and	and	CCONJ
aiua-11057	52	42	eleven	eleven	NUM
aiua-11057	52	43	patients	patient	NOUN
aiua-11057	52	44	(	(	PUNCT
aiua-11057	52	45	34	34	NUM
aiua-11057	52	46	%	%	NOUN
aiua-11057	52	47	)	)	PUNCT
aiua-11057	52	48	received	receive	VERB
aiua-11057	52	49	adjuvant	adjuvant	ADJ
aiua-11057	52	50	carboplatin	carboplatin	PROPN
aiua-11057	52	51	,	,	PUNCT
aiua-11057	52	52	with	with	ADP
aiua-11057	52	53	10	10	NUM
aiua-11057	52	54	patients	patient	NOUN
aiua-11057	52	55	receiving	receive	VERB
aiua-11057	52	56	only	only	ADV
aiua-11057	52	57	1	1	NUM
aiua-11057	52	58	cycle	cycle	NOUN
aiua-11057	52	59	and	and	CCONJ
aiua-11057	52	60	one	one	NUM
aiua-11057	52	61	patients	patient	NOUN
aiua-11057	52	62	receiving	receive	VERB
aiua-11057	52	63	2	2	NUM
aiua-11057	52	64	cycles	cycle	NOUN
aiua-11057	52	65	.	.	PUNCT
aiua-11057	53	1	patients	patient	NOUN
aiua-11057	53	2	'	'	PART
aiua-11057	53	3	clinical	clinical	ADJ
aiua-11057	53	4	and	and	CCONJ
aiua-11057	53	5	demographic	demographic	ADJ
aiua-11057	53	6	data	datum	NOUN
aiua-11057	53	7	in	in	ADP
aiua-11057	53	8	each	each	DET
aiua-11057	53	9	arm	arm	NOUN
aiua-11057	53	10	are	be	AUX
aiua-11057	53	11	summarized	summarize	VERB
aiua-11057	53	12	in	in	ADP
aiua-11057	53	13	table	table	NOUN
aiua-11057	53	14	2	2	NUM
aiua-11057	53	15	.	.	NUM
aiua-11057	53	16	five	five	NUM
aiua-11057	53	17	-	-	PUNCT
aiua-11057	53	18	year	year	NOUN
aiua-11057	53	19	overall	overall	ADJ
aiua-11057	53	20	survival	survival	NOUN
aiua-11057	53	21	rate	rate	NOUN
aiua-11057	53	22	was	be	AUX
aiua-11057	53	23	100	100	NUM
aiua-11057	53	24	%	%	NOUN
aiua-11057	53	25	in	in	ADP
aiua-11057	53	26	the	the	DET
aiua-11057	53	27	whole	whole	ADJ
aiua-11057	53	28	cohort	cohort	NOUN
aiua-11057	53	29	and	and	CCONJ
aiua-11057	53	30	median	median	ADJ
aiua-11057	53	31	overall	overall	ADJ
aiua-11057	53	32	survival	survival	NOUN
aiua-11057	53	33	was	be	AUX
aiua-11057	53	34	not	not	PART
aiua-11057	53	35	reached	reach	VERB
aiua-11057	53	36	.	.	PUNCT
aiua-11057	54	1	no	no	DET
aiua-11057	54	2	overall	overall	ADJ
aiua-11057	54	3	survival	survival	NOUN
aiua-11057	54	4	difference	difference	NOUN
aiua-11057	54	5	was	be	AUX
aiua-11057	54	6	seen	see	VERB
aiua-11057	54	7	between	between	ADP
aiua-11057	54	8	patients	patient	NOUN
aiua-11057	54	9	who	who	PRON
aiua-11057	54	10	were	be	AUX
aiua-11057	54	11	subjected	subject	VERB
aiua-11057	54	12	to	to	ADP
aiua-11057	54	13	active	active	ADJ
aiua-11057	54	14	treatment	treatment	NOUN
aiua-11057	54	15	and	and	CCONJ
aiua-11057	54	16	patients	patient	NOUN
aiua-11057	54	17	who	who	PRON
aiua-11057	54	18	were	be	AUX
aiua-11057	54	19	kept	keep	VERB
aiua-11057	54	20	under	under	ADP
aiua-11057	54	21	active	active	ADJ
aiua-11057	54	22	surveillance	surveillance	NOUN
aiua-11057	54	23	.	.	PUNCT
aiua-11057	55	1	in	in	ADP
aiua-11057	55	2	terms	term	NOUN
aiua-11057	55	3	of	of	ADP
aiua-11057	55	4	disease	disease	NOUN
aiua-11057	55	5	-	-	PUNCT
aiua-11057	55	6	free	free	ADJ
aiua-11057	55	7	survival	survival	NOUN
aiua-11057	55	8	,	,	PUNCT
aiua-11057	55	9	five	five	NUM
aiua-11057	55	10	year	year	NOUN
aiua-11057	55	11	dfs	dfs	PRON
aiua-11057	55	12	rate	rate	NOUN
aiua-11057	55	13	was	be	AUX
aiua-11057	55	14	100	100	NUM
aiua-11057	55	15	%	%	NOUN
aiua-11057	55	16	for	for	ADP
aiua-11057	55	17	patients	patient	NOUN
aiua-11057	55	18	who	who	PRON
aiua-11057	55	19	received	receive	VERB
aiua-11057	55	20	active	active	ADJ
aiua-11057	55	21	treatment	treatment	NOUN
aiua-11057	55	22	(	(	PUNCT
aiua-11057	55	23	whether	whether	SCONJ
aiua-11057	55	24	chemotherapy	chemotherapy	NOUN
aiua-11057	55	25	or	or	CCONJ
aiua-11057	55	26	radiotherapy	radiotherapy	NOUN
aiua-11057	55	27	)	)	PUNCT
aiua-11057	55	28	versus	versus	ADP
aiua-11057	55	29	93	93	NUM
aiua-11057	55	30	%	%	NOUN
aiua-11057	55	31	for	for	ADP
aiua-11057	55	32	patients	patient	NOUN
aiua-11057	55	33	who	who	PRON
aiua-11057	55	34	were	be	AUX
aiua-11057	55	35	kept	keep	VERB
aiua-11057	55	36	under	under	ADP
aiua-11057	55	37	active	active	ADJ
aiua-11057	55	38	surveillance	surveillance	NOUN
aiua-11057	55	39	(	(	PUNCT
aiua-11057	55	40	p	p	X
aiua-11057	55	41	=	=	NOUN
aiua-11057	55	42	0.03	0.03	NUM
aiua-11057	55	43	)	)	PUNCT
aiua-11057	55	44	.	.	PUNCT
aiua-11057	56	1	among	among	ADP
aiua-11057	56	2	those	those	PRON
aiua-11057	56	3	who	who	PRON
aiua-11057	56	4	were	be	AUX
aiua-11057	56	5	kept	keep	VERB
aiua-11057	56	6	under	under	ADP
aiua-11057	56	7	active	active	ADJ
aiua-11057	56	8	surveillance	surveillance	NOUN
aiua-11057	56	9	,	,	PUNCT
aiua-11057	56	10	one	one	NUM
aiua-11057	56	11	patient	patient	NOUN
aiua-11057	56	12	developed	develop	VERB
aiua-11057	56	13	para	para	NOUN
aiua-11057	56	14	-	-	PUNCT
aiua-11057	56	15	aortic	aortic	ADJ
aiua-11057	56	16	nodal	nodal	NOUN
aiua-11057	56	17	recurrence	recurrence	NOUN
aiua-11057	56	18	after	after	ADP
aiua-11057	56	19	4	4	NUM
aiua-11057	56	20	years	year	NOUN
aiua-11057	56	21	.	.	PUNCT
aiua-11057	57	1	he	he	PRON
aiua-11057	57	2	was	be	AUX
aiua-11057	57	3	managed	manage	VERB
aiua-11057	57	4	by	by	ADP
aiua-11057	57	5	salvage	salvage	NOUN
aiua-11057	57	6	chemotherapy	chemotherapy	NOUN
aiua-11057	57	7	(	(	PUNCT
aiua-11057	57	8	3	3	NUM
aiua-11057	57	9	cycles	cycle	NOUN
aiua-11057	57	10	bep	bep	PROPN
aiua-11057	57	11	)	)	PUNCT
aiua-11057	57	12	and	and	CCONJ
aiua-11057	57	13	he	he	PRON
aiua-11057	57	14	achieved	achieve	VERB
aiua-11057	57	15	complete	complete	ADJ
aiua-11057	57	16	response	response	NOUN
aiua-11057	57	17	and	and	CCONJ
aiua-11057	57	18	was	be	AUX
aiua-11057	57	19	disease	disease	NOUN
aiua-11057	57	20	free	free	ADJ
aiua-11057	57	21	till	till	SCONJ
aiua-11057	57	22	data	datum	NOUN
aiua-11057	57	23	cutoff	cutoff	NOUN
aiua-11057	57	24	.	.	PUNCT
aiua-11057	58	1	in	in	ADP
aiua-11057	58	2	terms	term	NOUN
aiua-11057	58	3	of	of	ADP
aiua-11057	58	4	loco	loco	PROPN
aiua-11057	58	5	-	-	PUNCT
aiua-11057	58	6	regional	regional	ADJ
aiua-11057	58	7	control	control	NOUN
aiua-11057	58	8	(	(	PUNCT
aiua-11057	58	9	lrc	lrc	PROPN
aiua-11057	58	10	)	)	PUNCT
aiua-11057	58	11	,	,	PUNCT
aiua-11057	58	12	five	five	NUM
aiua-11057	58	13	-	-	PUNCT
aiua-11057	58	14	year	year	NOUN
aiua-11057	58	15	lrc	lrc	NOUN
aiua-11057	58	16	was	be	AUX
aiua-11057	58	17	100	100	NUM
aiua-11057	58	18	%	%	NOUN
aiua-11057	58	19	for	for	ADP
aiua-11057	58	20	patients	patient	NOUN
aiua-11057	58	21	who	who	PRON
aiua-11057	58	22	received	receive	VERB
aiua-11057	58	23	active	active	ADJ
aiua-11057	58	24	treatment	treatment	NOUN
aiua-11057	58	25	(	(	PUNCT
aiua-11057	58	26	chemotherapy	chemotherapy	NOUN
aiua-11057	58	27	or	or	CCONJ
aiua-11057	58	28	radiotherapy	radiotherapy	NOUN
aiua-11057	58	29	)	)	PUNCT
aiua-11057	58	30	versus	versus	ADP
aiua-11057	58	31	93	93	NUM
aiua-11057	58	32	%	%	NOUN
aiua-11057	58	33	in	in	ADP
aiua-11057	58	34	patients	patient	NOUN
aiua-11057	58	35	who	who	PRON
aiua-11057	58	36	were	be	AUX
aiua-11057	58	37	kept	keep	VERB
aiua-11057	58	38	under	under	ADP
aiua-11057	58	39	active	active	ADJ
aiua-11057	58	40	surveillance	surveillance	NOUN
aiua-11057	58	41	(	(	PUNCT
aiua-11057	58	42	p	p	X
aiua-11057	58	43	=	=	NOUN
aiua-11057	58	44	0.03	0.03	NUM
aiua-11057	58	45	)	)	PUNCT
aiua-11057	58	46	.	.	PUNCT
aiua-11057	59	1	we	we	PRON
aiua-11057	59	2	tested	test	VERB
aiua-11057	59	3	proposed	propose	VERB
aiua-11057	59	4	factors	factor	NOUN
aiua-11057	59	5	that	that	PRON
aiua-11057	59	6	would	would	AUX
aiua-11057	59	7	affect	affect	VERB
aiua-11057	59	8	disease	disease	NOUN
aiua-11057	59	9	local	local	ADJ
aiua-11057	59	10	control	control	NOUN
aiua-11057	59	11	(	(	PUNCT
aiua-11057	59	12	namely	namely	ADV
aiua-11057	59	13	,	,	PUNCT
aiua-11057	59	14	rete	rete	NOUN
aiua-11057	59	15	testis	testis	NOUN
aiua-11057	59	16	invasion	invasion	NOUN
aiua-11057	59	17	and	and	CCONJ
aiua-11057	59	18	tumor	tumor	NOUN
aiua-11057	59	19	size	size	NOUN
aiua-11057	59	20	)	)	PUNCT
aiua-11057	59	21	,	,	PUNCT
aiua-11057	59	22	however	however	ADV
aiua-11057	59	23	,	,	PUNCT
aiua-11057	59	24	none	none	NOUN
aiua-11057	59	25	of	of	ADP
aiua-11057	59	26	them	they	PRON
aiua-11057	59	27	had	have	VERB
aiua-11057	59	28	a	a	DET
aiua-11057	59	29	significant	significant	ADJ
aiua-11057	59	30	difference	difference	NOUN
aiua-11057	59	31	in	in	ADP
aiua-11057	59	32	relation	relation	NOUN
aiua-11057	59	33	to	to	ADP
aiua-11057	59	34	lrc	lrc	PROPN
aiua-11057	59	35	in	in	ADP
aiua-11057	59	36	univariate	univariate	ADJ
aiua-11057	59	37	analysis	analysis	NOUN
aiua-11057	59	38	.	.	PUNCT
aiua-11057	60	1	fifteen	fifteen	NUM
aiua-11057	60	2	patients	patient	NOUN
aiua-11057	60	3	had	have	VERB
aiua-11057	60	4	rete	rete	NOUN
aiua-11057	60	5	-	-	PUNCT
aiua-11057	60	6	testis	testis	ADJ
aiua-11057	60	7	invasion	invasion	NOUN
aiua-11057	60	8	versus	versus	ADP
aiua-11057	60	9	18	18	NUM
aiua-11057	60	10	patients	patient	NOUN
aiua-11057	60	11	without	without	ADP
aiua-11057	60	12	invasion	invasion	NOUN
aiua-11057	60	13	,	,	PUNCT
aiua-11057	60	14	with	with	ADP
aiua-11057	60	15	5	5	NUM
aiua-11057	60	16	year	year	NOUN
aiua-11057	60	17	lrc	lrc	NOUN
aiua-11057	60	18	of	of	ADP
aiua-11057	60	19	80	80	NUM
aiua-11057	60	20	versus	versus	ADP
aiua-11057	60	21	100	100	NUM
aiua-11057	60	22	percent	percent	NOUN
aiua-11057	60	23	,	,	PUNCT
aiua-11057	60	24	respectively	respectively	ADV
aiua-11057	60	25	(	(	PUNCT
aiua-11057	60	26	p	p	X
aiua-11057	60	27	=	=	NOUN
aiua-11057	60	28	0.439	0.439	NUM
aiua-11057	60	29	)	)	PUNCT
aiua-11057	60	30	.	.	PUNCT
aiua-11057	61	1	sixteen	sixteen	NUM
aiua-11057	61	2	patients	patient	NOUN
aiua-11057	61	3	had	have	VERB
aiua-11057	61	4	tumor	tumor	NOUN
aiua-11057	61	5	size	size	NOUN
aiua-11057	61	6	>	>	X
aiua-11057	61	7	4	4	NUM
aiua-11057	61	8	cm	cm	NOUN
aiua-11057	61	9	versus	versus	ADP
aiua-11057	61	10	seventeen	seventeen	NUM
aiua-11057	61	11	patients	patient	NOUN
aiua-11057	61	12	with	with	ADP
aiua-11057	61	13	tumor	tumor	NOUN
aiua-11057	61	14	size	size	NOUN
aiua-11057	61	15	<	<	X
aiua-11057	61	16	4	4	NUM
aiua-11057	61	17	cm	cm	NOUN
aiua-11057	61	18	,	,	PUNCT
aiua-11057	61	19	with	with	ADP
aiua-11057	61	20	five	five	NUM
aiua-11057	61	21	year	year	NOUN
aiua-11057	61	22	lrc	lrc	PROPN
aiua-11057	61	23	100	100	NUM
aiua-11057	61	24	percent	percent	NOUN
aiua-11057	61	25	and	and	CCONJ
aiua-11057	61	26	75	75	NUM
aiua-11057	61	27	percent	percent	NOUN
aiua-11057	61	28	,	,	PUNCT
aiua-11057	61	29	respectively	respectively	ADV
aiua-11057	61	30	(	(	PUNCT
aiua-11057	61	31	p=0.317	p=0.317	NUM
aiua-11057	61	32	)	)	PUNCT
aiua-11057	61	33	.	.	PUNCT
aiua-11057	62	1	in	in	ADP
aiua-11057	62	2	terms	term	NOUN
aiua-11057	62	3	of	of	ADP
aiua-11057	62	4	metastasis	metastasis	NOUN
aiua-11057	62	5	-	-	PUNCT
aiua-11057	62	6	free	free	ADJ
aiua-11057	62	7	survival	survival	NOUN
aiua-11057	62	8	(	(	PUNCT
aiua-11057	62	9	mfs	mfs	PROPN
aiua-11057	62	10	)	)	PUNCT
aiua-11057	62	11	,	,	PUNCT
aiua-11057	62	12	five	five	NUM
aiua-11057	62	13	-	-	PUNCT
aiua-11057	62	14	year	year	NOUN
aiua-11057	62	15	mfs	mfs	NOUN
aiua-11057	62	16	rate	rate	NOUN
aiua-11057	62	17	was	be	AUX
aiua-11057	62	18	100	100	NUM
aiua-11057	62	19	%	%	NOUN
aiua-11057	62	20	in	in	ADP
aiua-11057	62	21	all	all	DET
aiua-11057	62	22	patients	patient	NOUN
aiua-11057	62	23	,	,	PUNCT
aiua-11057	62	24	regardless	regardless	ADV
aiua-11057	62	25	the	the	DET
aiua-11057	62	26	modality	modality	NOUN
aiua-11057	62	27	used	use	VERB
aiua-11057	62	28	.	.	PUNCT
aiua-11057	63	1	there	there	PRON
aiua-11057	63	2	has	have	AUX
aiua-11057	63	3	been	be	AUX
aiua-11057	63	4	a	a	DET
aiua-11057	63	5	change	change	NOUN
aiua-11057	63	6	in	in	ADP
aiua-11057	63	7	the	the	DET
aiua-11057	63	8	pattern	pattern	NOUN
aiua-11057	63	9	of	of	ADP
aiua-11057	63	10	care	care	NOUN
aiua-11057	63	11	in	in	ADP
aiua-11057	63	12	our	our	PRON
aiua-11057	63	13	study	study	NOUN
aiua-11057	63	14	population	population	NOUN
aiua-11057	63	15	over	over	ADP
aiua-11057	63	16	the	the	DET
aiua-11057	63	17	studied	studied	ADJ
aiua-11057	63	18	years	year	NOUN
aiua-11057	63	19	.	.	PUNCT
aiua-11057	64	1	in	in	ADP
aiua-11057	64	2	the	the	DET
aiua-11057	64	3	period	period	NOUN
aiua-11057	64	4	from	from	ADP
aiua-11057	64	5	2005	2005	NUM
aiua-11057	64	6	till	till	SCONJ
aiua-11057	64	7	2009	2009	NUM
aiua-11057	64	8	the	the	DET
aiua-11057	64	9	majority	majority	NOUN
aiua-11057	64	10	of	of	ADP
aiua-11057	64	11	the	the	DET
aiua-11057	64	12	patients	patient	NOUN
aiua-11057	64	13	were	be	AUX
aiua-11057	64	14	treated	treat	VERB
aiua-11057	64	15	with	with	ADP
aiua-11057	64	16	adjuvant	adjuvant	ADJ
aiua-11057	64	17	radiation	radiation	NOUN
aiua-11057	64	18	therapy	therapy	NOUN
aiua-11057	64	19	.	.	PUNCT
aiua-11057	65	1	in	in	ADP
aiua-11057	65	2	the	the	DET
aiua-11057	65	3	period	period	NOUN
aiua-11057	65	4	from	from	ADP
aiua-11057	65	5	2010	2010	NUM
aiua-11057	65	6	till	till	SCONJ
aiua-11057	65	7	2014	2014	NUM
aiua-11057	65	8	chemotherapy	chemotherapy	NOUN
aiua-11057	65	9	was	be	AUX
aiua-11057	65	10	the	the	DET
aiua-11057	65	11	modality	modality	NOUN
aiua-11057	65	12	of	of	ADP
aiua-11057	65	13	choice	choice	NOUN
aiua-11057	65	14	,	,	PUNCT
aiua-11057	65	15	while	while	SCONJ
aiua-11057	65	16	in	in	ADP
aiua-11057	65	17	the	the	DET
aiua-11057	65	18	recent	recent	ADJ
aiua-11057	65	19	years	year	NOUN
aiua-11057	65	20	from	from	ADP
aiua-11057	65	21	2015	2015	NUM
aiua-11057	65	22	till	till	SCONJ
aiua-11057	65	23	2019	2019	NUM
aiua-11057	65	24	active	active	ADJ
aiua-11057	65	25	surveillance	surveillance	NOUN
aiua-11057	65	26	was	be	AUX
aiua-11057	65	27	the	the	DET
aiua-11057	65	28	treatment	treatment	NOUN
aiua-11057	65	29	of	of	ADP
aiua-11057	65	30	choice	choice	NOUN
aiua-11057	65	31	(	(	PUNCT
aiua-11057	65	32	figure	figure	NOUN
aiua-11057	65	33	1	1	NUM
aiua-11057	65	34	)	)	PUNCT
aiua-11057	65	35	.	.	PUNCT
aiua-11057	66	1	table	table	NOUN
aiua-11057	66	2	1	1	NUM
aiua-11057	66	3	.	.	PUNCT
aiua-11057	67	1	demographic	demographic	ADJ
aiua-11057	67	2	,	,	PUNCT
aiua-11057	67	3	clinical	clinical	ADJ
aiua-11057	67	4	data	datum	NOUN
aiua-11057	67	5	and	and	CCONJ
aiua-11057	67	6	pathological	pathological	ADJ
aiua-11057	67	7	subtypes	subtype	NOUN
aiua-11057	67	8	in	in	ADP
aiua-11057	67	9	patients	patient	NOUN
aiua-11057	67	10	of	of	ADP
aiua-11057	67	11	stage	stage	NOUN
aiua-11057	67	12	i	i	PRON
aiua-11057	67	13	seminoma	seminoma	VERB
aiua-11057	67	14	.	.	PUNCT
aiua-11057	68	1	n	n	NOUN
aiua-11057	68	2	=	=	SYM
aiua-11057	68	3	35	35	NUM
aiua-11057	68	4	n	n	NOUN
aiua-11057	68	5	(	(	PUNCT
aiua-11057	68	6	%	%	NOUN
aiua-11057	68	7	)	)	PUNCT
aiua-11057	68	8	age	age	NOUN
aiua-11057	68	9	(	(	PUNCT
aiua-11057	68	10	median	median	NOUN
aiua-11057	68	11	35	35	NUM
aiua-11057	68	12	,	,	PUNCT
aiua-11057	68	13	range	range	VERB
aiua-11057	68	14	19	19	NUM
aiua-11057	68	15	-	-	SYM
aiua-11057	68	16	52	52	NUM
aiua-11057	68	17	)	)	PUNCT
aiua-11057	68	18	<	<	X
aiua-11057	68	19	35	35	NUM
aiua-11057	68	20	20	20	NUM
aiua-11057	68	21	(	(	PUNCT
aiua-11057	68	22	57	57	NUM
aiua-11057	68	23	)	)	PUNCT
aiua-11057	68	24	>	>	X
aiua-11057	68	25	35	35	NUM
aiua-11057	68	26	15	15	NUM
aiua-11057	68	27	(	(	PUNCT
aiua-11057	68	28	43	43	NUM
aiua-11057	68	29	)	)	PUNCT
aiua-11057	68	30	history	history	NOUN
aiua-11057	68	31	of	of	ADP
aiua-11057	68	32	undescended	undescended	ADJ
aiua-11057	68	33	testis	testis	NOUN
aiua-11057	69	1	yes	yes	INTJ
aiua-11057	69	2	6	6	NUM
aiua-11057	69	3	(	(	PUNCT
aiua-11057	69	4	17	17	NUM
aiua-11057	69	5	)	)	PUNCT
aiua-11057	69	6	no	no	DET
aiua-11057	69	7	29	29	NUM
aiua-11057	69	8	(	(	PUNCT
aiua-11057	69	9	83	83	NUM
aiua-11057	69	10	)	)	PUNCT
aiua-11057	69	11	history	history	NOUN
aiua-11057	69	12	of	of	ADP
aiua-11057	69	13	contralateral	contralateral	ADJ
aiua-11057	69	14	seminoma	seminoma	NOUN
aiua-11057	69	15	yes	yes	INTJ
aiua-11057	69	16	1	1	NUM
aiua-11057	69	17	(	(	PUNCT
aiua-11057	69	18	3	3	NUM
aiua-11057	69	19	)	)	PUNCT
aiua-11057	69	20	no	no	DET
aiua-11057	69	21	34	34	NUM
aiua-11057	69	22	(	(	PUNCT
aiua-11057	69	23	97	97	NUM
aiua-11057	69	24	)	)	PUNCT
aiua-11057	69	25	pathological	pathological	ADJ
aiua-11057	69	26	subtypes	subtype	NOUN
aiua-11057	69	27	classic	classic	ADJ
aiua-11057	69	28	32	32	NUM
aiua-11057	69	29	(	(	PUNCT
aiua-11057	69	30	91	91	NUM
aiua-11057	69	31	)	)	PUNCT
aiua-11057	69	32	spermatocytic	spermatocytic	ADJ
aiua-11057	69	33	3	3	NUM
aiua-11057	69	34	(	(	PUNCT
aiua-11057	69	35	9	9	NUM
aiua-11057	69	36	)	)	PUNCT
aiua-11057	69	37	anaplastic	anaplastic	ADJ
aiua-11057	69	38	0	0	NUM
aiua-11057	70	1	(	(	PUNCT
aiua-11057	70	2	0	0	NUM
aiua-11057	70	3	)	)	PUNCT
aiua-11057	70	4	table	table	NOUN
aiua-11057	70	5	2	2	NUM
aiua-11057	70	6	.	.	PUNCT
aiua-11057	71	1	characteristics	characteristic	NOUN
aiua-11057	71	2	of	of	ADP
aiua-11057	71	3	the	the	DET
aiua-11057	71	4	patients	patient	NOUN
aiua-11057	71	5	in	in	ADP
aiua-11057	71	6	each	each	DET
aiua-11057	71	7	modality	modality	NOUN
aiua-11057	71	8	.	.	PUNCT
aiua-11057	72	1	active	active	ADJ
aiua-11057	72	2	surveillance	surveillance	NOUN
aiua-11057	72	3	chemotherapy	chemotherapy	NOUN
aiua-11057	72	4	radiotherapy	radiotherapy	NOUN
aiua-11057	72	5	(	(	PUNCT
aiua-11057	72	6	14	14	NUM
aiua-11057	72	7	)	)	PUNCT
aiua-11057	72	8	(	(	PUNCT
aiua-11057	72	9	11	11	NUM
aiua-11057	72	10	)	)	PUNCT
aiua-11057	72	11	(	(	PUNCT
aiua-11057	72	12	8)	8)	NUM
aiua-11057	72	13	age	age	NOUN
aiua-11057	72	14	<	<	X
aiua-11057	72	15	35	35	NUM
aiua-11057	72	16	11	11	NUM
aiua-11057	72	17	4	4	NUM
aiua-11057	72	18	5	5	NUM
aiua-11057	72	19	>	>	SYM
aiua-11057	72	20	35	35	NUM
aiua-11057	72	21	3	3	NUM
aiua-11057	72	22	7	7	NUM
aiua-11057	72	23	3	3	NUM
aiua-11057	72	24	history	history	NOUN
aiua-11057	72	25	of	of	ADP
aiua-11057	72	26	undescended	undescended	ADJ
aiua-11057	72	27	testis	testis	NOUN
aiua-11057	72	28	2	2	NUM
aiua-11057	72	29	3	3	NUM
aiua-11057	72	30	1	1	NUM
aiua-11057	72	31	history	history	NOUN
aiua-11057	72	32	of	of	ADP
aiua-11057	72	33	contralateral	contralateral	ADJ
aiua-11057	72	34	seminoma	seminoma	NOUN
aiua-11057	72	35	1	1	NUM
aiua-11057	72	36	0	0	NUM
aiua-11057	72	37	0	0	NUM
aiua-11057	72	38	pathological	pathological	ADJ
aiua-11057	72	39	subtype	subtype	NOUN
aiua-11057	72	40	classic	classic	ADJ
aiua-11057	72	41	14	14	NUM
aiua-11057	72	42	9	9	NUM
aiua-11057	72	43	7	7	NUM
aiua-11057	72	44	spermatocytic	spermatocytic	ADJ
aiua-11057	72	45	0	0	NUM
aiua-11057	72	46	2	2	NUM
aiua-11057	72	47	1	1	NUM
aiua-11057	72	48	archivio	archivio	NOUN
aiua-11057	72	49	italiano	italiano	NOUN
aiua-11057	72	50	di	di	X
aiua-11057	72	51	urologia	urologia	PROPN
aiua-11057	72	52	e	e	PROPN
aiua-11057	72	53	andrologia	andrologia	NOUN
aiua-11057	72	54	2023	2023	NUM
aiua-11057	72	55	;	;	PUNCT
aiua-11057	72	56	95	95	NUM
aiua-11057	72	57	,	,	PUNCT
aiua-11057	72	58	1	1	NUM
aiua-11057	72	59	management	management	NOUN
aiua-11057	72	60	of	of	ADP
aiua-11057	72	61	clinical	clinical	ADJ
aiua-11057	72	62	stage	stage	NOUN
aiua-11057	72	63	i	i	PRON
aiua-11057	72	64	seminoma	seminoma	VERB
aiua-11057	72	65	discussion	discussion	NOUN
aiua-11057	72	66	this	this	DET
aiua-11057	72	67	retrospective	retrospective	ADJ
aiua-11057	72	68	study	study	NOUN
aiua-11057	72	69	included	include	VERB
aiua-11057	72	70	33	33	NUM
aiua-11057	72	71	patients	patient	NOUN
aiua-11057	72	72	with	with	ADP
aiua-11057	72	73	stage	stage	NOUN
aiua-11057	72	74	i	i	PRON
aiua-11057	72	75	seminoma	seminoma	VERB
aiua-11057	72	76	who	who	PRON
aiua-11057	72	77	presented	present	VERB
aiua-11057	72	78	to	to	ADP
aiua-11057	72	79	nci	nci	PROPN
aiua-11057	72	80	cairo	cairo	PROPN
aiua-11057	72	81	university	university	PROPN
aiua-11057	72	82	in	in	ADP
aiua-11057	72	83	the	the	DET
aiua-11057	72	84	period	period	NOUN
aiua-11057	72	85	from	from	ADP
aiua-11057	72	86	2005	2005	NUM
aiua-11057	72	87	to	to	ADP
aiua-11057	72	88	2019	2019	NUM
aiua-11057	72	89	.	.	PUNCT
aiua-11057	73	1	several	several	ADJ
aiua-11057	73	2	epidemiological	epidemiological	ADJ
aiua-11057	73	3	and	and	CCONJ
aiua-11057	73	4	clinical	clinical	ADJ
aiua-11057	73	5	factors	factor	NOUN
aiua-11057	73	6	were	be	AUX
aiua-11057	73	7	studied	study	VERB
aiua-11057	73	8	as	as	ADV
aiua-11057	73	9	well	well	ADV
aiua-11057	73	10	as	as	ADP
aiua-11057	73	11	treatment	treatment	NOUN
aiua-11057	73	12	strategies	strategy	NOUN
aiua-11057	73	13	potentially	potentially	ADV
aiua-11057	73	14	influencing	influence	VERB
aiua-11057	73	15	disease	disease	NOUN
aiua-11057	73	16	-	-	PUNCT
aiua-11057	73	17	free	free	ADJ
aiua-11057	73	18	survival	survival	NOUN
aiua-11057	73	19	(	(	PUNCT
aiua-11057	73	20	dfs	dfs	PROPN
aiua-11057	73	21	)	)	PUNCT
aiua-11057	73	22	in	in	ADP
aiua-11057	73	23	addition	addition	NOUN
aiua-11057	73	24	to	to	ADP
aiua-11057	73	25	overall	overall	ADJ
aiua-11057	73	26	survival	survival	NOUN
aiua-11057	73	27	(	(	PUNCT
aiua-11057	73	28	os	os	NOUN
aiua-11057	73	29	)	)	PUNCT
aiua-11057	73	30	and	and	CCONJ
aiua-11057	73	31	loco	loco	PROPN
aiua-11057	73	32	regional	regional	ADJ
aiua-11057	73	33	recurrence	recurrence	NOUN
aiua-11057	73	34	(	(	PUNCT
aiua-11057	73	35	lrr	lrr	ADJ
aiua-11057	73	36	)	)	PUNCT
aiua-11057	73	37	.	.	PUNCT
aiua-11057	74	1	in	in	ADP
aiua-11057	74	2	our	our	PRON
aiua-11057	74	3	study	study	NOUN
aiua-11057	74	4	the	the	DET
aiua-11057	74	5	median	median	PROPN
aiua-11057	74	6	os	os	NOUN
aiua-11057	74	7	was	be	AUX
aiua-11057	74	8	not	not	PART
aiua-11057	74	9	reached	reach	VERB
aiua-11057	74	10	,	,	PUNCT
aiua-11057	74	11	with	with	ADP
aiua-11057	74	12	5	5	NUM
aiua-11057	74	13	year	year	NOUN
aiua-11057	74	14	overall	overall	ADJ
aiua-11057	74	15	survival	survival	NOUN
aiua-11057	74	16	100	100	NUM
aiua-11057	74	17	%	%	NOUN
aiua-11057	74	18	in	in	ADP
aiua-11057	74	19	stage	stage	NOUN
aiua-11057	74	20	i	i	PRON
aiua-11057	74	21	seminoma	seminoma	VERB
aiua-11057	74	22	.	.	PUNCT
aiua-11057	75	1	this	this	PRON
aiua-11057	75	2	is	be	AUX
aiua-11057	75	3	consistent	consistent	ADJ
aiua-11057	75	4	with	with	ADP
aiua-11057	75	5	many	many	ADJ
aiua-11057	75	6	other	other	ADJ
aiua-11057	75	7	data	datum	NOUN
aiua-11057	75	8	.	.	PUNCT
aiua-11057	76	1	for	for	ADP
aiua-11057	76	2	example	example	NOUN
aiua-11057	76	3	,	,	PUNCT
aiua-11057	76	4	a	a	DET
aiua-11057	76	5	five	five	NUM
aiua-11057	76	6	-	-	PUNCT
aiua-11057	76	7	year	year	NOUN
aiua-11057	76	8	survival	survival	NOUN
aiua-11057	76	9	of	of	ADP
aiua-11057	76	10	99.0	99.0	NUM
aiua-11057	76	11	%	%	NOUN
aiua-11057	76	12	was	be	AUX
aiua-11057	76	13	reported	report	VERB
aiua-11057	76	14	in	in	ADP
aiua-11057	76	15	seer	seer	PROPN
aiua-11057	76	16	statistics	statistic	NOUN
aiua-11057	76	17	published	publish	VERB
aiua-11057	76	18	in	in	ADP
aiua-11057	76	19	the	the	DET
aiua-11057	76	20	year	year	NOUN
aiua-11057	76	21	20165	20165	NUM
aiua-11057	76	22	.	.	PUNCT
aiua-11057	77	1	in	in	ADP
aiua-11057	77	2	another	another	DET
aiua-11057	77	3	large	large	ADJ
aiua-11057	77	4	cohort	cohort	NOUN
aiua-11057	77	5	study	study	NOUN
aiua-11057	77	6	of	of	ADP
aiua-11057	77	7	ncdb	ncdb	NOUN
aiua-11057	77	8	involving	involve	VERB
aiua-11057	77	9	33,094	33,094	NUM
aiua-11057	77	10	patients	patient	NOUN
aiua-11057	77	11	,	,	PUNCT
aiua-11057	77	12	a	a	DET
aiua-11057	77	13	ten	ten	NUM
aiua-11057	77	14	year	year	NOUN
aiua-11057	77	15	survival	survival	NOUN
aiua-11057	77	16	rate	rate	NOUN
aiua-11057	77	17	of	of	ADP
aiua-11057	77	18	95	95	NUM
aiua-11057	77	19	%	%	NOUN
aiua-11057	77	20	was	be	AUX
aiua-11057	77	21	reported	report	VERB
aiua-11057	77	22	for	for	ADP
aiua-11057	77	23	patients	patient	NOUN
aiua-11057	77	24	who	who	PRON
aiua-11057	77	25	received	receive	VERB
aiua-11057	77	26	active	active	ADJ
aiua-11057	77	27	treatment	treatment	NOUN
aiua-11057	77	28	and	and	CCONJ
aiua-11057	77	29	93.4	93.4	NUM
aiua-11057	77	30	%	%	NOUN
aiua-11057	77	31	for	for	ADP
aiua-11057	77	32	patients	patient	NOUN
aiua-11057	77	33	who	who	PRON
aiua-11057	77	34	were	be	AUX
aiua-11057	77	35	kept	keep	VERB
aiua-11057	77	36	under	under	ADP
aiua-11057	77	37	active	active	ADJ
aiua-11057	77	38	surveillance	surveillance	NOUN
aiua-11057	77	39	(	(	PUNCT
aiua-11057	77	40	4	4	NUM
aiua-11057	77	41	)	)	PUNCT
aiua-11057	77	42	.	.	PUNCT
aiua-11057	78	1	in	in	ADP
aiua-11057	78	2	another	another	DET
aiua-11057	78	3	series	series	NOUN
aiua-11057	78	4	coming	come	VERB
aiua-11057	78	5	from	from	ADP
aiua-11057	78	6	a	a	DET
aiua-11057	78	7	tertiary	tertiary	ADJ
aiua-11057	78	8	portuguese	portuguese	ADJ
aiua-11057	78	9	center	center	NOUN
aiua-11057	78	10	addressing	address	VERB
aiua-11057	78	11	testicular	testicular	ADJ
aiua-11057	78	12	cancer	cancer	NOUN
aiua-11057	78	13	,	,	PUNCT
aiua-11057	78	14	the	the	DET
aiua-11057	78	15	five	five	NUM
aiua-11057	78	16	year	year	NOUN
aiua-11057	78	17	survival	survival	NOUN
aiua-11057	78	18	rate	rate	NOUN
aiua-11057	78	19	for	for	ADP
aiua-11057	78	20	seminoma	seminoma	NOUN
aiua-11057	78	21	patients	patient	NOUN
aiua-11057	78	22	'	'	PART
aiua-11057	78	23	was	be	AUX
aiua-11057	78	24	100	100	NUM
aiua-11057	78	25	percent	percent	NOUN
aiua-11057	78	26	(	(	PUNCT
aiua-11057	78	27	6	6	NUM
aiua-11057	78	28	)	)	PUNCT
aiua-11057	78	29	.	.	PUNCT
aiua-11057	79	1	the	the	DET
aiua-11057	79	2	5	5	NUM
aiua-11057	79	3	year	year	NOUN
aiua-11057	79	4	disease	disease	NOUN
aiua-11057	79	5	-	-	PUNCT
aiua-11057	79	6	free	free	ADJ
aiua-11057	79	7	survival	survival	NOUN
aiua-11057	79	8	in	in	ADP
aiua-11057	79	9	patients	patient	NOUN
aiua-11057	79	10	received	receive	VERB
aiua-11057	79	11	adjuvant	adjuvant	ADJ
aiua-11057	79	12	radiotherapy	radiotherapy	NOUN
aiua-11057	79	13	to	to	ADP
aiua-11057	79	14	para	para	NOUN
aiua-11057	79	15	-	-	PUNCT
aiua-11057	79	16	aortic	aortic	ADJ
aiua-11057	79	17	chain	chain	NOUN
aiua-11057	79	18	or	or	CCONJ
aiua-11057	79	19	single	single	ADJ
aiua-11057	79	20	agent	agent	NOUN
aiua-11057	79	21	carboplatin	carboplatin	NOUN
aiua-11057	79	22	was	be	AUX
aiua-11057	79	23	100	100	NUM
aiua-11057	79	24	percent	percent	NOUN
aiua-11057	79	25	,	,	PUNCT
aiua-11057	79	26	which	which	PRON
aiua-11057	79	27	is	be	AUX
aiua-11057	79	28	consistent	consistent	ADJ
aiua-11057	79	29	with	with	ADP
aiua-11057	79	30	the	the	DET
aiua-11057	79	31	study	study	NOUN
aiua-11057	79	32	conducted	conduct	VERB
aiua-11057	79	33	by	by	ADP
aiua-11057	79	34	oliver	oliver	PROPN
aiua-11057	79	35	et	et	PROPN
aiua-11057	79	36	al	al	PROPN
aiua-11057	79	37	.	.	PROPN
aiua-11057	79	38	comparing	compare	VERB
aiua-11057	79	39	adjuvant	adjuvant	ADJ
aiua-11057	79	40	1	1	NUM
aiua-11057	79	41	cycle	cycle	NOUN
aiua-11057	79	42	carboplatin	carboplatin	NOUN
aiua-11057	79	43	versus	versus	ADP
aiua-11057	79	44	radiotherapy	radiotherapy	NOUN
aiua-11057	79	45	showing	show	VERB
aiua-11057	79	46	relapsefree	relapsefree	NOUN
aiua-11057	79	47	survival	survival	NOUN
aiua-11057	79	48	rates	rate	NOUN
aiua-11057	79	49	at	at	ADP
aiua-11057	79	50	5	5	NUM
aiua-11057	79	51	years	year	NOUN
aiua-11057	79	52	of	of	ADP
aiua-11057	79	53	94.7	94.7	NUM
aiua-11057	79	54	and	and	CCONJ
aiua-11057	79	55	96	96	NUM
aiua-11057	79	56	percent	percent	NOUN
aiua-11057	79	57	,	,	PUNCT
aiua-11057	79	58	respectively	respectively	ADV
aiua-11057	79	59	(	(	PUNCT
aiua-11057	79	60	7	7	NUM
aiua-11057	79	61	)	)	PUNCT
aiua-11057	79	62	.	.	PUNCT
aiua-11057	80	1	the	the	DET
aiua-11057	80	2	5	5	NUM
aiua-11057	80	3	year	year	NOUN
aiua-11057	80	4	dfs	dfs	NOUN
aiua-11057	80	5	and	and	CCONJ
aiua-11057	80	6	the	the	DET
aiua-11057	80	7	5	5	NUM
aiua-11057	80	8	-	-	PUNCT
aiua-11057	80	9	year	year	NOUN
aiua-11057	80	10	loco	loco	NOUN
aiua-11057	80	11	-	-	PUNCT
aiua-11057	80	12	regional	regional	ADJ
aiua-11057	80	13	control	control	NOUN
aiua-11057	80	14	in	in	ADP
aiua-11057	80	15	our	our	PRON
aiua-11057	80	16	study	study	NOUN
aiua-11057	80	17	was	be	AUX
aiua-11057	80	18	93	93	NUM
aiua-11057	80	19	%	%	NOUN
aiua-11057	80	20	in	in	ADP
aiua-11057	80	21	arm	arm	NOUN
aiua-11057	80	22	of	of	ADP
aiua-11057	80	23	surveillance	surveillance	NOUN
aiua-11057	80	24	with	with	ADP
aiua-11057	80	25	complete	complete	ADJ
aiua-11057	80	26	cure	cure	NOUN
aiua-11057	80	27	of	of	ADP
aiua-11057	80	28	the	the	DET
aiua-11057	80	29	relapse	relapse	NOUN
aiua-11057	80	30	and	and	CCONJ
aiua-11057	80	31	100	100	NUM
aiua-11057	80	32	%	%	NOUN
aiua-11057	80	33	in	in	ADP
aiua-11057	80	34	both	both	DET
aiua-11057	80	35	radiation	radiation	NOUN
aiua-11057	80	36	and	and	CCONJ
aiua-11057	80	37	chemotherapy	chemotherapy	NOUN
aiua-11057	80	38	groups	group	NOUN
aiua-11057	80	39	.	.	PUNCT
aiua-11057	81	1	in	in	ADP
aiua-11057	81	2	a	a	DET
aiua-11057	81	3	study	study	NOUN
aiua-11057	81	4	conducted	conduct	VERB
aiua-11057	81	5	by	by	ADP
aiua-11057	81	6	dieckmann	dieckmann	PROPN
aiua-11057	81	7	et	et	PROPN
aiua-11057	81	8	al	al	PROPN
aiua-11057	81	9	.	.	PROPN
aiua-11057	81	10	,	,	PUNCT
aiua-11057	81	11	the	the	DET
aiua-11057	81	12	use	use	NOUN
aiua-11057	81	13	of	of	ADP
aiua-11057	81	14	one	one	NUM
aiua-11057	81	15	course	course	NOUN
aiua-11057	81	16	of	of	ADP
aiua-11057	81	17	adjuvant	adjuvant	ADJ
aiua-11057	81	18	carboplatin	carboplatin	NOUN
aiua-11057	81	19	,	,	PUNCT
aiua-11057	81	20	surveillance	surveillance	NOUN
aiua-11057	81	21	and	and	CCONJ
aiua-11057	81	22	radiotherapy	radiotherapy	NOUN
aiua-11057	81	23	were	be	AUX
aiua-11057	81	24	compared	compare	VERB
aiua-11057	81	25	to	to	ADP
aiua-11057	81	26	each	each	DET
aiua-11057	81	27	other	other	ADJ
aiua-11057	81	28	.	.	PUNCT
aiua-11057	82	1	the	the	DET
aiua-11057	82	2	results	result	NOUN
aiua-11057	82	3	showed	show	VERB
aiua-11057	82	4	a	a	DET
aiua-11057	82	5	disease	disease	NOUN
aiua-11057	82	6	-	-	PUNCT
aiua-11057	82	7	specific	specific	ADJ
aiua-11057	82	8	survival	survival	NOUN
aiua-11057	82	9	of	of	ADP
aiua-11057	82	10	100	100	NUM
aiua-11057	82	11	%	%	NOUN
aiua-11057	82	12	irrespective	irrespective	ADV
aiua-11057	82	13	of	of	ADP
aiua-11057	82	14	the	the	DET
aiua-11057	82	15	post	post	ADJ
aiua-11057	82	16	-	-	ADJ
aiua-11057	82	17	operative	operative	ADJ
aiua-11057	82	18	approach	approach	NOUN
aiua-11057	82	19	.	.	PUNCT
aiua-11057	83	1	crude	crude	ADJ
aiua-11057	83	2	relapse	relapse	NOUN
aiua-11057	83	3	rates	rate	NOUN
aiua-11057	83	4	were	be	AUX
aiua-11057	83	5	8.2	8.2	NUM
aiua-11057	83	6	,	,	PUNCT
aiua-11057	83	7	2.4	2.4	NUM
aiua-11057	83	8	,	,	PUNCT
aiua-11057	83	9	5.0	5.0	NUM
aiua-11057	83	10	,	,	PUNCT
aiua-11057	83	11	and	and	CCONJ
aiua-11057	83	12	1.5	1.5	NUM
aiua-11057	83	13	%	%	NOUN
aiua-11057	83	14	for	for	ADP
aiua-11057	83	15	surveillance	surveillance	NOUN
aiua-11057	83	16	,	,	PUNCT
aiua-11057	83	17	radiotherapy	radiotherapy	NOUN
aiua-11057	83	18	,	,	PUNCT
aiua-11057	83	19	1	1	NUM
aiua-11057	83	20	cycle	cycle	NOUN
aiua-11057	83	21	carboplatin	carboplatin	NOUN
aiua-11057	83	22	,	,	PUNCT
aiua-11057	83	23	and	and	CCONJ
aiua-11057	83	24	2	2	NUM
aiua-11057	83	25	cycles	cycle	NOUN
aiua-11057	83	26	carboplatin	carboplatin	NOUN
aiua-11057	83	27	,	,	PUNCT
aiua-11057	83	28	respectively	respectively	ADV
aiua-11057	83	29	,	,	PUNCT
aiua-11057	83	30	after	after	SCONJ
aiua-11057	83	31	a	a	DET
aiua-11057	83	32	median	median	NOUN
aiua-11057	83	33	follow	follow	VERB
aiua-11057	83	34	up	up	ADP
aiua-11057	83	35	of	of	ADP
aiua-11057	83	36	30	30	NUM
aiua-11057	83	37	months	month	NOUN
aiua-11057	83	38	.	.	PUNCT
aiua-11057	84	1	in	in	ADP
aiua-11057	84	2	this	this	DET
aiua-11057	84	3	study	study	NOUN
aiua-11057	84	4	,	,	PUNCT
aiua-11057	84	5	all	all	DET
aiua-11057	84	6	recurrences	recurrence	NOUN
aiua-11057	84	7	were	be	AUX
aiua-11057	84	8	salvageable	salvageable	ADJ
aiua-11057	84	9	leading	lead	VERB
aiua-11057	84	10	to	to	ADP
aiua-11057	84	11	a	a	DET
aiua-11057	84	12	disease	disease	NOUN
aiua-11057	84	13	-	-	PUNCT
aiua-11057	84	14	specific	specific	ADJ
aiua-11057	84	15	survival	survival	NOUN
aiua-11057	84	16	rate	rate	NOUN
aiua-11057	84	17	of	of	ADP
aiua-11057	84	18	100	100	NUM
aiua-11057	84	19	percent	percent	NOUN
aiua-11057	84	20	,	,	PUNCT
aiua-11057	84	21	with	with	ADP
aiua-11057	84	22	no	no	DET
aiua-11057	84	23	statistical	statistical	ADJ
aiua-11057	84	24	difference	difference	NOUN
aiua-11057	84	25	in	in	ADP
aiua-11057	84	26	the	the	DET
aiua-11057	84	27	incidences	incidence	NOUN
aiua-11057	84	28	of	of	ADP
aiua-11057	84	29	relapses	relapse	NOUN
aiua-11057	84	30	among	among	ADP
aiua-11057	84	31	the	the	DET
aiua-11057	84	32	four	four	NUM
aiua-11057	84	33	treatment	treatment	NOUN
aiua-11057	84	34	arms	arm	NOUN
aiua-11057	84	35	(	(	PUNCT
aiua-11057	84	36	log	log	NOUN
aiua-11057	84	37	-	-	PUNCT
aiua-11057	84	38	rank	rank	NOUN
aiua-11057	84	39	,	,	PUNCT
aiua-11057	84	40	p	p	X
aiua-11057	84	41	=	=	PROPN
aiua-11057	84	42	0.0573	0.0573	NUM
aiua-11057	84	43	)	)	PUNCT
aiua-11057	84	44	(	(	PUNCT
aiua-11057	84	45	8)	8)	NUM
aiua-11057	84	46	.	.	PUNCT
aiua-11057	85	1	in	in	ADP
aiua-11057	85	2	this	this	DET
aiua-11057	85	3	study	study	NOUN
aiua-11057	85	4	,	,	PUNCT
aiua-11057	85	5	the	the	DET
aiua-11057	85	6	proposed	propose	VERB
aiua-11057	85	7	risk	risk	NOUN
aiua-11057	85	8	factors	factor	NOUN
aiua-11057	85	9	of	of	ADP
aiua-11057	85	10	local	local	ADJ
aiua-11057	85	11	recurrence	recurrence	NOUN
aiua-11057	85	12	in	in	ADP
aiua-11057	85	13	stage	stage	NOUN
aiua-11057	85	14	i	i	PRON
aiua-11057	85	15	seminoma	seminoma	VERB
aiua-11057	85	16	(	(	PUNCT
aiua-11057	85	17	namely	namely	ADV
aiua-11057	85	18	,	,	PUNCT
aiua-11057	85	19	rete	rete	NOUN
aiua-11057	85	20	-	-	ADJ
aiua-11057	85	21	testis	testis	NOUN
aiua-11057	85	22	invasion	invasion	NOUN
aiua-11057	85	23	and	and	CCONJ
aiua-11057	85	24	tumor	tumor	NOUN
aiua-11057	85	25	size	size	NOUN
aiua-11057	85	26	>	>	X
aiua-11057	85	27	4	4	NUM
aiua-11057	85	28	cm	cm	NOUN
aiua-11057	85	29	)	)	PUNCT
aiua-11057	85	30	did	do	AUX
aiua-11057	85	31	n’t	not	PART
aiua-11057	85	32	show	show	VERB
aiua-11057	85	33	any	any	DET
aiua-11057	85	34	adverse	adverse	ADJ
aiua-11057	85	35	impact	impact	NOUN
aiua-11057	85	36	on	on	ADP
aiua-11057	85	37	local	local	ADJ
aiua-11057	85	38	control	control	NOUN
aiua-11057	85	39	for	for	ADP
aiua-11057	85	40	patients	patient	NOUN
aiua-11057	85	41	.	.	PUNCT
aiua-11057	86	1	in	in	ADP
aiua-11057	86	2	comparison	comparison	NOUN
aiua-11057	86	3	to	to	ADP
aiua-11057	86	4	literature	literature	NOUN
aiua-11057	86	5	,	,	PUNCT
aiua-11057	86	6	this	this	PRON
aiua-11057	86	7	might	might	AUX
aiua-11057	86	8	be	be	AUX
aiua-11057	86	9	a	a	DET
aiua-11057	86	10	little	little	ADJ
aiua-11057	86	11	bit	bit	NOUN
aiua-11057	86	12	different	different	ADJ
aiua-11057	86	13	.	.	PUNCT
aiua-11057	87	1	a	a	DET
aiua-11057	87	2	risk	risk	NOUN
aiua-11057	87	3	-	-	PUNCT
aiua-11057	87	4	adapted	adapt	VERB
aiua-11057	87	5	adjuvant	adjuvant	ADJ
aiua-11057	87	6	management	management	NOUN
aiua-11057	87	7	was	be	AUX
aiua-11057	87	8	adopted	adopt	VERB
aiua-11057	87	9	by	by	ADP
aiua-11057	87	10	the	the	DET
aiua-11057	87	11	swedish	swedish	ADJ
aiua-11057	87	12	and	and	CCONJ
aiua-11057	87	13	norwegian	norwegian	ADJ
aiua-11057	87	14	testicular	testicular	ADJ
aiua-11057	87	15	cancer	cancer	NOUN
aiua-11057	87	16	group	group	NOUN
aiua-11057	87	17	based	base	VERB
aiua-11057	87	18	on	on	ADP
aiua-11057	87	19	their	their	PRON
aiua-11057	87	20	prospective	prospective	ADJ
aiua-11057	87	21	trial	trial	NOUN
aiua-11057	87	22	involving	involve	VERB
aiua-11057	87	23	almost	almost	ADV
aiua-11057	87	24	900	900	NUM
aiua-11057	87	25	patients	patient	NOUN
aiua-11057	87	26	.	.	PUNCT
aiua-11057	88	1	the	the	DET
aiua-11057	88	2	study	study	NOUN
aiua-11057	88	3	population	population	NOUN
aiua-11057	88	4	developed	develop	VERB
aiua-11057	88	5	69	69	NUM
aiua-11057	88	6	relapses	relapse	NOUN
aiua-11057	88	7	;	;	PUNCT
aiua-11057	88	8	with	with	ADP
aiua-11057	88	9	29	29	NUM
aiua-11057	88	10	relapses	relapse	NOUN
aiua-11057	88	11	among	among	ADP
aiua-11057	88	12	patients	patient	NOUN
aiua-11057	88	13	who	who	PRON
aiua-11057	88	14	were	be	AUX
aiua-11057	88	15	managed	manage	VERB
aiua-11057	88	16	by	by	ADP
aiua-11057	88	17	surveillance	surveillance	NOUN
aiua-11057	88	18	and	and	CCONJ
aiua-11057	88	19	40	40	NUM
aiua-11057	88	20	relapses	relapse	NOUN
aiua-11057	88	21	in	in	ADP
aiua-11057	88	22	patients	patient	NOUN
aiua-11057	88	23	managed	manage	VERB
aiua-11057	88	24	with	with	ADP
aiua-11057	88	25	adjuvant	adjuvant	ADJ
aiua-11057	88	26	1	1	NUM
aiua-11057	88	27	cycle	cycle	NOUN
aiua-11057	88	28	carboplatin	carboplatin	NOUN
aiua-11057	88	29	.	.	PUNCT
aiua-11057	89	1	the	the	DET
aiua-11057	89	2	invasion	invasion	NOUN
aiua-11057	89	3	of	of	ADP
aiua-11057	89	4	the	the	DET
aiua-11057	89	5	rete	rete	NOUN
aiua-11057	89	6	testis	testis	NOUN
aiua-11057	89	7	[	[	X
aiua-11057	89	8	hazard	hazard	NOUN
aiua-11057	89	9	ratio	ratio	NOUN
aiua-11057	89	10	(	(	PUNCT
aiua-11057	89	11	hr	hr	NOUN
aiua-11057	89	12	)	)	PUNCT
aiua-11057	89	13	1.9	1.9	NUM
aiua-11057	89	14	,	,	PUNCT
aiua-11057	89	15	p	p	X
aiua-11057	89	16	=	=	NOUN
aiua-11057	89	17	0.011	0.011	NUM
aiua-11057	89	18	]	]	PUNCT
aiua-11057	89	19	and	and	CCONJ
aiua-11057	89	20	tumor	tumor	NOUN
aiua-11057	89	21	diameter	diameter	NOUN
aiua-11057	89	22	>	>	X
aiua-11057	89	23	4	4	NUM
aiua-11057	89	24	cm	cm	NOUN
aiua-11057	89	25	(	(	PUNCT
aiua-11057	89	26	hr	hr	NOUN
aiua-11057	89	27	2.7	2.7	NUM
aiua-11057	89	28	,	,	PUNCT
aiua-11057	89	29	p	p	X
aiua-11057	89	30	<	<	X
aiua-11057	89	31	0.001	0.001	NUM
aiua-11057	89	32	)	)	PUNCT
aiua-11057	89	33	were	be	AUX
aiua-11057	89	34	identified	identify	VERB
aiua-11057	89	35	as	as	ADP
aiua-11057	89	36	risk	risk	NOUN
aiua-11057	89	37	factors	factor	NOUN
aiua-11057	89	38	for	for	ADP
aiua-11057	89	39	disease	disease	NOUN
aiua-11057	89	40	relapse	relapse	NOUN
aiua-11057	89	41	.	.	PUNCT
aiua-11057	90	1	in	in	ADP
aiua-11057	90	2	patients	patient	NOUN
aiua-11057	90	3	without	without	ADP
aiua-11057	90	4	any	any	PRON
aiua-11057	90	5	of	of	ADP
aiua-11057	90	6	these	these	DET
aiua-11057	90	7	factors	factor	NOUN
aiua-11057	90	8	,	,	PUNCT
aiua-11057	90	9	the	the	DET
aiua-11057	90	10	relapse	relapse	NOUN
aiua-11057	90	11	rate	rate	NOUN
aiua-11057	90	12	was	be	AUX
aiua-11057	90	13	4.0	4.0	NUM
aiua-11057	90	14	%	%	NOUN
aiua-11057	90	15	for	for	ADP
aiua-11057	90	16	patients	patient	NOUN
aiua-11057	90	17	in	in	ADP
aiua-11057	90	18	surveillance	surveillance	NOUN
aiua-11057	90	19	arm	arm	NOUN
aiua-11057	90	20	versus	versus	ADP
aiua-11057	90	21	2.2	2.2	NUM
aiua-11057	90	22	%	%	NOUN
aiua-11057	90	23	in	in	ADP
aiua-11057	90	24	patients	patient	NOUN
aiua-11057	90	25	receiving	receive	VERB
aiua-11057	90	26	adjuvant	adjuvant	ADJ
aiua-11057	90	27	carboplatin	carboplatin	NOUN
aiua-11057	90	28	.	.	PUNCT
aiua-11057	91	1	in	in	ADP
aiua-11057	91	2	patients	patient	NOUN
aiua-11057	91	3	with	with	ADP
aiua-11057	91	4	one	one	NUM
aiua-11057	91	5	or	or	CCONJ
aiua-11057	91	6	two	two	NUM
aiua-11057	91	7	risk	risk	NOUN
aiua-11057	91	8	factors	factor	NOUN
aiua-11057	91	9	,	,	PUNCT
aiua-11057	91	10	the	the	DET
aiua-11057	91	11	relapse	relapse	NOUN
aiua-11057	91	12	rate	rate	NOUN
aiua-11057	91	13	was	be	AUX
aiua-11057	91	14	15.5	15.5	NUM
aiua-11057	91	15	%	%	NOUN
aiua-11057	91	16	in	in	ADP
aiua-11057	91	17	patients	patient	NOUN
aiua-11057	91	18	managed	manage	VERB
aiua-11057	91	19	by	by	ADP
aiua-11057	91	20	surveillance	surveillance	NOUN
aiua-11057	91	21	versus	versus	ADP
aiua-11057	91	22	9.3	9.3	NUM
aiua-11057	91	23	%	%	NOUN
aiua-11057	91	24	in	in	ADP
aiua-11057	91	25	patients	patient	NOUN
aiua-11057	91	26	receiving	receive	VERB
aiua-11057	91	27	adjuvant	adjuvant	ADJ
aiua-11057	91	28	carboplatin	carboplatin	NOUN
aiua-11057	91	29	(	(	PUNCT
aiua-11057	91	30	9	9	NUM
aiua-11057	91	31	)	)	PUNCT
aiua-11057	91	32	.	.	PUNCT
aiua-11057	92	1	in	in	ADP
aiua-11057	92	2	another	another	DET
aiua-11057	92	3	systematic	systematic	ADJ
aiua-11057	92	4	review	review	NOUN
aiua-11057	92	5	including	include	VERB
aiua-11057	92	6	nineteen	nineteen	NUM
aiua-11057	92	7	studies	study	NOUN
aiua-11057	92	8	addressing	address	VERB
aiua-11057	92	9	prognostic	prognostic	ADJ
aiua-11057	92	10	factors	factor	NOUN
aiua-11057	92	11	for	for	ADP
aiua-11057	92	12	disease	disease	NOUN
aiua-11057	92	13	relapse	relapse	NOUN
aiua-11057	92	14	in	in	ADP
aiua-11057	92	15	clinical	clinical	ADJ
aiua-11057	92	16	stage	stage	NOUN
aiua-11057	92	17	i	i	PRON
aiua-11057	92	18	seminoma	seminoma	VERB
aiua-11057	92	19	patients	patient	NOUN
aiua-11057	92	20	'	'	PART
aiua-11057	92	21	managed	manage	VERB
aiua-11057	92	22	by	by	ADP
aiua-11057	92	23	surveillance	surveillance	NOUN
aiua-11057	92	24	(	(	PUNCT
aiua-11057	92	25	10	10	NUM
aiua-11057	92	26	)	)	PUNCT
aiua-11057	92	27	,	,	PUNCT
aiua-11057	92	28	rete	rete	NOUN
aiua-11057	92	29	testis	testis	NOUN
aiua-11057	92	30	invasion	invasion	NOUN
aiua-11057	92	31	was	be	AUX
aiua-11057	92	32	identified	identify	VERB
aiua-11057	92	33	as	as	ADP
aiua-11057	92	34	a	a	DET
aiua-11057	92	35	significant	significant	ADJ
aiua-11057	92	36	factor	factor	NOUN
aiua-11057	92	37	for	for	ADP
aiua-11057	92	38	relapse	relapse	NOUN
aiua-11057	92	39	in	in	ADP
aiua-11057	92	40	only	only	ADV
aiua-11057	92	41	4	4	NUM
aiua-11057	92	42	out	out	ADP
aiua-11057	92	43	of	of	ADP
aiua-11057	92	44	13	13	NUM
aiua-11057	92	45	studies	study	NOUN
aiua-11057	92	46	,	,	PUNCT
aiua-11057	92	47	while	while	SCONJ
aiua-11057	92	48	tumor	tumor	NOUN
aiua-11057	92	49	size	size	NOUN
aiua-11057	92	50	was	be	AUX
aiua-11057	92	51	a	a	DET
aiua-11057	92	52	significant	significant	ADJ
aiua-11057	92	53	factor	factor	NOUN
aiua-11057	92	54	for	for	ADP
aiua-11057	92	55	relapse	relapse	NOUN
aiua-11057	92	56	in	in	ADP
aiua-11057	92	57	10	10	NUM
aiua-11057	92	58	out	out	ADP
aiua-11057	92	59	of	of	ADP
aiua-11057	92	60	14	14	NUM
aiua-11057	92	61	studies	study	NOUN
aiua-11057	92	62	.	.	PUNCT
aiua-11057	93	1	the	the	DET
aiua-11057	93	2	authors	author	NOUN
aiua-11057	93	3	'	'	PART
aiua-11057	93	4	conclusion	conclusion	NOUN
aiua-11057	93	5	was	be	AUX
aiua-11057	93	6	that	that	DET
aiua-11057	93	7	size	size	NOUN
aiua-11057	93	8	of	of	ADP
aiua-11057	93	9	tumor	tumor	NOUN
aiua-11057	93	10	is	be	AUX
aiua-11057	93	11	the	the	DET
aiua-11057	93	12	most	most	ADV
aiua-11057	93	13	important	important	ADJ
aiua-11057	93	14	prognostic	prognostic	ADJ
aiua-11057	93	15	factor	factor	NOUN
aiua-11057	93	16	for	for	ADP
aiua-11057	93	17	disease	disease	NOUN
aiua-11057	93	18	relapse	relapse	NOUN
aiua-11057	93	19	,	,	PUNCT
aiua-11057	93	20	but	but	CCONJ
aiua-11057	93	21	the	the	DET
aiua-11057	93	22	authors	author	NOUN
aiua-11057	93	23	failed	fail	VERB
aiua-11057	93	24	to	to	PART
aiua-11057	93	25	define	define	VERB
aiua-11057	93	26	a	a	DET
aiua-11057	93	27	clear	clear	ADJ
aiua-11057	93	28	cutoff	cutoff	NOUN
aiua-11057	93	29	value	value	NOUN
aiua-11057	93	30	for	for	ADP
aiua-11057	93	31	tumor	tumor	NOUN
aiua-11057	93	32	size	size	NOUN
aiua-11057	93	33	and	and	CCONJ
aiua-11057	93	34	that	that	SCONJ
aiua-11057	93	35	rete	rete	NOUN
aiua-11057	93	36	-	-	PUNCT
aiua-11057	93	37	testis	testis	NOUN
aiua-11057	93	38	invasion	invasion	NOUN
aiua-11057	93	39	was	be	AUX
aiua-11057	93	40	a	a	DET
aiua-11057	93	41	minor	minor	ADJ
aiua-11057	93	42	risk	risk	NOUN
aiua-11057	93	43	factor	factor	NOUN
aiua-11057	93	44	for	for	ADP
aiua-11057	93	45	disease	disease	NOUN
aiua-11057	93	46	recurrence	recurrence	NOUN
aiua-11057	93	47	.	.	PUNCT
aiua-11057	94	1	however	however	ADV
aiua-11057	94	2	,	,	PUNCT
aiua-11057	94	3	the	the	DET
aiua-11057	94	4	most	most	ADV
aiua-11057	94	5	recent	recent	ADJ
aiua-11057	94	6	version	version	NOUN
aiua-11057	94	7	of	of	ADP
aiua-11057	94	8	nccn	nccn	ADJ
aiua-11057	94	9	guidelines	guideline	NOUN
aiua-11057	94	10	still	still	ADV
aiua-11057	94	11	recommends	recommend	VERB
aiua-11057	94	12	for	for	ADP
aiua-11057	94	13	active	active	ADJ
aiua-11057	94	14	surveillance	surveillance	NOUN
aiua-11057	94	15	as	as	ADP
aiua-11057	94	16	the	the	DET
aiua-11057	94	17	preferred	preferred	ADJ
aiua-11057	94	18	option	option	NOUN
aiua-11057	94	19	of	of	ADP
aiua-11057	94	20	management	management	NOUN
aiua-11057	94	21	for	for	ADP
aiua-11057	94	22	patients	patient	NOUN
aiua-11057	94	23	with	with	ADP
aiua-11057	94	24	clinical	clinical	ADJ
aiua-11057	94	25	stage	stage	NOUN
aiua-11057	94	26	i	i	PRON
aiua-11057	94	27	seminoma	seminoma	VERB
aiua-11057	94	28	,	,	PUNCT
aiua-11057	94	29	regardless	regardless	ADV
aiua-11057	94	30	tumor	tumor	NOUN
aiua-11057	94	31	size	size	NOUN
aiua-11057	94	32	or	or	CCONJ
aiua-11057	94	33	rete	rete	NOUN
aiua-11057	94	34	-	-	PUNCT
aiua-11057	94	35	testis	testis	NOUN
aiua-11057	94	36	invasion	invasion	NOUN
aiua-11057	94	37	,	,	PUNCT
aiua-11057	94	38	given	give	VERB
aiua-11057	94	39	the	the	DET
aiua-11057	94	40	equal	equal	ADJ
aiua-11057	94	41	survival	survival	NOUN
aiua-11057	94	42	of	of	ADP
aiua-11057	94	43	surveillance	surveillance	NOUN
aiua-11057	94	44	versus	versus	ADP
aiua-11057	94	45	active	active	ADJ
aiua-11057	94	46	treatment	treatment	NOUN
aiua-11057	94	47	,	,	PUNCT
aiua-11057	94	48	potential	potential	ADJ
aiua-11057	94	49	long	long	ADJ
aiua-11057	94	50	term	term	NOUN
aiua-11057	94	51	treatment	treatment	NOUN
aiua-11057	94	52	toxicities	toxicity	NOUN
aiua-11057	94	53	especially	especially	ADV
aiua-11057	94	54	with	with	ADP
aiua-11057	94	55	the	the	DET
aiua-11057	94	56	expected	expect	VERB
aiua-11057	94	57	long	long	ADJ
aiua-11057	94	58	term	term	NOUN
aiua-11057	94	59	survival	survival	NOUN
aiua-11057	94	60	of	of	ADP
aiua-11057	94	61	the	the	DET
aiua-11057	94	62	patients	patient	NOUN
aiua-11057	94	63	and	and	CCONJ
aiua-11057	94	64	high	high	ADJ
aiua-11057	94	65	salvage	salvage	NOUN
aiua-11057	94	66	rates	rate	NOUN
aiua-11057	94	67	of	of	ADP
aiua-11057	94	68	any	any	DET
aiua-11057	94	69	recurrences	recurrence	NOUN
aiua-11057	94	70	,	,	PUNCT
aiua-11057	94	71	provided	provide	VERB
aiua-11057	94	72	that	that	SCONJ
aiua-11057	94	73	patients	patient	NOUN
aiua-11057	94	74	will	will	AUX
aiua-11057	94	75	commit	commit	VERB
aiua-11057	94	76	to	to	ADP
aiua-11057	94	77	the	the	DET
aiua-11057	94	78	surveillance	surveillance	NOUN
aiua-11057	94	79	protocol	protocol	NOUN
aiua-11057	94	80	(	(	PUNCT
aiua-11057	94	81	11	11	NUM
aiua-11057	94	82	)	)	PUNCT
aiua-11057	94	83	.	.	PUNCT
aiua-11057	95	1	this	this	DET
aiua-11057	95	2	study	study	NOUN
aiua-11057	95	3	also	also	ADV
aiua-11057	95	4	shows	show	VERB
aiua-11057	95	5	a	a	DET
aiua-11057	95	6	change	change	NOUN
aiua-11057	95	7	in	in	ADP
aiua-11057	95	8	our	our	PRON
aiua-11057	95	9	pattern	pattern	NOUN
aiua-11057	95	10	of	of	ADP
aiua-11057	95	11	care	care	NOUN
aiua-11057	95	12	with	with	ADP
aiua-11057	95	13	time	time	NOUN
aiua-11057	95	14	from	from	ADP
aiua-11057	95	15	adjuvant	adjuvant	ADJ
aiua-11057	95	16	radiation	radiation	NOUN
aiua-11057	95	17	to	to	ADP
aiua-11057	95	18	para	para	NOUN
aiua-11057	95	19	-	-	PUNCT
aiua-11057	95	20	aortic	aortic	ADJ
aiua-11057	95	21	chain	chain	NOUN
aiua-11057	95	22	towards	towards	ADP
aiua-11057	95	23	single	single	ADJ
aiua-11057	95	24	agent	agent	NOUN
aiua-11057	95	25	carboplatin	carboplatin	NOUN
aiua-11057	95	26	and	and	CCONJ
aiua-11057	95	27	active	active	ADJ
aiua-11057	95	28	surveillance	surveillance	NOUN
aiua-11057	95	29	,	,	PUNCT
aiua-11057	95	30	given	give	VERB
aiua-11057	95	31	the	the	DET
aiua-11057	95	32	change	change	NOUN
aiua-11057	95	33	in	in	ADP
aiua-11057	95	34	the	the	DET
aiua-11057	95	35	international	international	ADJ
aiua-11057	95	36	guidelines	guideline	NOUN
aiua-11057	95	37	.	.	PUNCT
aiua-11057	96	1	study	study	NOUN
aiua-11057	96	2	limitations	limitation	NOUN
aiua-11057	96	3	include	include	VERB
aiua-11057	96	4	the	the	DET
aiua-11057	96	5	retrospective	retrospective	ADJ
aiua-11057	96	6	nature	nature	NOUN
aiua-11057	96	7	of	of	ADP
aiua-11057	96	8	the	the	DET
aiua-11057	96	9	study	study	NOUN
aiua-11057	96	10	with	with	ADP
aiua-11057	96	11	the	the	DET
aiua-11057	96	12	inherent	inherent	ADJ
aiua-11057	96	13	selection	selection	NOUN
aiua-11057	96	14	bias	bias	NOUN
aiua-11057	96	15	in	in	ADP
aiua-11057	96	16	this	this	DET
aiua-11057	96	17	type	type	NOUN
aiua-11057	96	18	of	of	ADP
aiua-11057	96	19	studies	study	NOUN
aiua-11057	96	20	(	(	PUNCT
aiua-11057	96	21	reserving	reserve	VERB
aiua-11057	96	22	active	active	ADJ
aiua-11057	96	23	treatment	treatment	NOUN
aiua-11057	96	24	for	for	ADP
aiua-11057	96	25	fit	fit	ADJ
aiua-11057	96	26	and	and	CCONJ
aiua-11057	96	27	younger	young	ADJ
aiua-11057	96	28	patients	patient	NOUN
aiua-11057	96	29	or	or	CCONJ
aiua-11057	96	30	those	those	PRON
aiua-11057	96	31	who	who	PRON
aiua-11057	96	32	can	can	AUX
aiua-11057	96	33	not	not	PART
aiua-11057	96	34	adhere	adhere	VERB
aiua-11057	96	35	to	to	ADP
aiua-11057	96	36	the	the	DET
aiua-11057	96	37	follow	follow	VERB
aiua-11057	96	38	up	up	ADP
aiua-11057	96	39	schedule	schedule	NOUN
aiua-11057	96	40	)	)	PUNCT
aiua-11057	96	41	,	,	PUNCT
aiua-11057	96	42	the	the	DET
aiua-11057	96	43	heterogeneous	heterogeneous	ADJ
aiua-11057	96	44	groups	group	NOUN
aiua-11057	96	45	of	of	ADP
aiua-11057	96	46	patients	patient	NOUN
aiua-11057	96	47	with	with	ADP
aiua-11057	96	48	imbalance	imbalance	NOUN
aiua-11057	96	49	between	between	ADP
aiua-11057	96	50	treatment	treatment	NOUN
aiua-11057	96	51	arms	arm	NOUN
aiua-11057	96	52	and	and	CCONJ
aiua-11057	96	53	lack	lack	NOUN
aiua-11057	96	54	of	of	ADP
aiua-11057	96	55	qol	qol	NOUN
aiua-11057	96	56	assessment	assessment	NOUN
aiua-11057	96	57	with	with	ADP
aiua-11057	96	58	each	each	DET
aiua-11057	96	59	treatment	treatment	NOUN
aiua-11057	96	60	modality	modality	NOUN
aiua-11057	96	61	.	.	PUNCT
aiua-11057	97	1	in	in	ADP
aiua-11057	97	2	summary	summary	NOUN
aiua-11057	97	3	,	,	PUNCT
aiua-11057	97	4	our	our	PRON
aiua-11057	97	5	study	study	NOUN
aiua-11057	97	6	highlights	highlight	NOUN
aiua-11057	97	7	and	and	CCONJ
aiua-11057	97	8	confirms	confirm	VERB
aiua-11057	97	9	the	the	DET
aiua-11057	97	10	data	datum	NOUN
aiua-11057	97	11	stating	state	VERB
aiua-11057	97	12	that	that	DET
aiua-11057	97	13	stage	stage	NOUN
aiua-11057	97	14	i	i	PRON
aiua-11057	97	15	seminoma	seminoma	VERB
aiua-11057	97	16	can	can	AUX
aiua-11057	97	17	be	be	AUX
aiua-11057	97	18	treated	treat	VERB
aiua-11057	97	19	by	by	ADP
aiua-11057	97	20	different	different	ADJ
aiua-11057	97	21	adjuvant	adjuvant	ADJ
aiua-11057	97	22	modalities	modality	NOUN
aiua-11057	97	23	(	(	PUNCT
aiua-11057	97	24	radiotherapy	radiotherapy	NOUN
aiua-11057	97	25	,	,	PUNCT
aiua-11057	97	26	carboplatin	carboplatin	NOUN
aiua-11057	97	27	or	or	CCONJ
aiua-11057	97	28	active	active	ADJ
aiua-11057	97	29	surveillance	surveillance	NOUN
aiua-11057	97	30	)	)	PUNCT
aiua-11057	97	31	with	with	ADP
aiua-11057	97	32	similar	similar	ADJ
aiua-11057	97	33	outcomes	outcome	NOUN
aiua-11057	97	34	in	in	ADP
aiua-11057	97	35	terms	term	NOUN
aiua-11057	97	36	of	of	ADP
aiua-11057	97	37	dfs	dfs	PROPN
aiua-11057	97	38	,	,	PUNCT
aiua-11057	97	39	lrc	lrc	PROPN
aiua-11057	97	40	and	and	CCONJ
aiua-11057	97	41	os	os	NOUN
aiua-11057	97	42	.	.	PUNCT
aiua-11057	98	1	active	active	ADJ
aiua-11057	98	2	surveillance	surveillance	NOUN
aiua-11057	98	3	remains	remain	VERB
aiua-11057	98	4	an	an	DET
aiua-11057	98	5	appealing	appealing	ADJ
aiua-11057	98	6	treatment	treatment	NOUN
aiua-11057	98	7	option	option	NOUN
aiua-11057	98	8	given	give	VERB
aiua-11057	98	9	similar	similar	ADJ
aiua-11057	98	10	survival	survival	NOUN
aiua-11057	98	11	compared	compare	VERB
aiua-11057	98	12	to	to	ADP
aiua-11057	98	13	active	active	ADJ
aiua-11057	98	14	treatment	treatment	NOUN
aiua-11057	98	15	and	and	CCONJ
aiua-11057	98	16	complete	complete	ADJ
aiua-11057	98	17	cure	cure	NOUN
aiua-11057	98	18	after	after	ADP
aiua-11057	98	19	salvage	salvage	NOUN
aiua-11057	98	20	with	with	ADP
aiua-11057	98	21	chemotherapy	chemotherapy	NOUN
aiua-11057	98	22	in	in	ADP
aiua-11057	98	23	relapsing	relapse	VERB
aiua-11057	98	24	patients	patient	NOUN
aiua-11057	98	25	.	.	PUNCT
aiua-11057	99	1	figure	figure	NOUN
aiua-11057	99	2	1	1	NUM
aiua-11057	99	3	.	.	PUNCT
aiua-11057	100	1	change	change	NOUN
aiua-11057	100	2	in	in	ADP
aiua-11057	100	3	the	the	DET
aiua-11057	100	4	patterns	pattern	NOUN
aiua-11057	100	5	of	of	ADP
aiua-11057	100	6	care	care	NOUN
aiua-11057	100	7	along	along	ADP
aiua-11057	100	8	time	time	NOUN
aiua-11057	100	9	from	from	ADP
aiua-11057	100	10	2005	2005	NUM
aiua-11057	100	11	till	till	SCONJ
aiua-11057	100	12	2019	2019	NUM
aiua-11057	100	13	.	.	PUNCT
aiua-11057	101	1	archivio	archivio	NOUN
aiua-11057	101	2	italiano	italiano	PROPN
aiua-11057	101	3	di	di	X
aiua-11057	101	4	urologia	urologia	PROPN
aiua-11057	101	5	e	e	PROPN
aiua-11057	101	6	andrologia	andrologia	NOUN
aiua-11057	101	7	2023	2023	NUM
aiua-11057	101	8	;	;	PUNCT
aiua-11057	101	9	95	95	NUM
aiua-11057	101	10	,	,	PUNCT
aiua-11057	101	11	1	1	NUM
aiua-11057	101	12	m.	m.	NOUN
aiua-11057	101	13	mahmoud	mahmoud	PROPN
aiua-11057	101	14	sayed	sayed	PROPN
aiua-11057	101	15	,	,	PUNCT
aiua-11057	101	16	a.	a.	PROPN
aiua-11057	101	17	mohamad	mohamad	PROPN
aiua-11057	101	18	nasr	nasr	PROPN
aiua-11057	101	19	,	,	PUNCT
aiua-11057	101	20	i.	i.	PROPN
aiua-11057	101	21	mohamad	mohamad	PROPN
aiua-11057	101	22	saad	saad	PROPN
aiua-11057	101	23	eldin	eldin	PROPN
aiua-11057	101	24	,	,	PUNCT
aiua-11057	101	25	y.	y.	PROPN
aiua-11057	101	26	anwar	anwar	PROPN
aiua-11057	101	27	abdelazim	abdelazim	PROPN
aiua-11057	101	28	references	reference	NOUN
aiua-11057	101	29	1	1	NUM
aiua-11057	101	30	.	.	PUNCT
aiua-11057	102	1	seer	seer	PROPN
aiua-11057	102	2	cancer	cancer	NOUN
aiua-11057	102	3	statistics	statistic	NOUN
aiua-11057	102	4	factsheets	factsheet	NOUN
aiua-11057	102	5	:	:	PUNCT
aiua-11057	102	6	testicular	testicular	ADJ
aiua-11057	102	7	cancer	cancer	NOUN
aiua-11057	102	8	.	.	PUNCT
aiua-11057	103	1	national	national	PROPN
aiua-11057	103	2	cancer	cancer	PROPN
aiua-11057	103	3	institute	institute	PROPN
aiua-11057	103	4	.	.	PUNCT
aiua-11057	104	1	bethesda	bethesda	PROPN
aiua-11057	104	2	,	,	PUNCT
aiua-11057	104	3	md	md	PROPN
aiua-11057	104	4	.	.	PROPN
aiua-11057	104	5	2020	2020	NUM
aiua-11057	104	6	.	.	PUNCT
aiua-11057	105	1	2	2	X
aiua-11057	105	2	.	.	X
aiua-11057	105	3	jones	jones	PROPN
aiua-11057	105	4	rh	rh	PROPN
aiua-11057	105	5	,	,	PUNCT
aiua-11057	105	6	vasey	vasey	PROPN
aiua-11057	105	7	pa	pa	PROPN
aiua-11057	105	8	.	.	PROPN
aiua-11057	105	9	part	part	PROPN
aiua-11057	106	1	i	i	NOUN
aiua-11057	106	2	:	:	PUNCT
aiua-11057	106	3	testicular	testicular	ADJ
aiua-11057	106	4	cancer	cancer	NOUN
aiua-11057	106	5	--	--	PUNCT
aiua-11057	106	6	management	management	NOUN
aiua-11057	106	7	of	of	ADP
aiua-11057	106	8	early	early	ADJ
aiua-11057	106	9	disease	disease	NOUN
aiua-11057	106	10	.	.	PUNCT
aiua-11057	107	1	lancet	lancet	PROPN
aiua-11057	107	2	oncol	oncol	PROPN
aiua-11057	107	3	.	.	PUNCT
aiua-11057	108	1	2003	2003	NUM
aiua-11057	108	2	;	;	PUNCT
aiua-11057	108	3	4:730	4:730	NUM
aiua-11057	108	4	-	-	SYM
aiua-11057	108	5	7	7	NUM
aiua-11057	108	6	.	.	NOUN
aiua-11057	108	7	3	3	X
aiua-11057	108	8	.	.	X
aiua-11057	108	9	mead	mead	PROPN
aiua-11057	108	10	gm	gm	PROPN
aiua-11057	108	11	,	,	PUNCT
aiua-11057	108	12	fossa	fossa	ADJ
aiua-11057	108	13	sd	sd	ADP
aiua-11057	108	14	,	,	PUNCT
aiua-11057	108	15	oliver	oliver	PROPN
aiua-11057	108	16	rt	rt	PROPN
aiua-11057	108	17	,	,	PUNCT
aiua-11057	108	18	et	et	PROPN
aiua-11057	108	19	al	al	PROPN
aiua-11057	108	20	.	.	PROPN
aiua-11057	108	21	randomized	randomize	VERB
aiua-11057	108	22	trials	trial	NOUN
aiua-11057	108	23	in	in	ADP
aiua-11057	108	24	2466	2466	NUM
aiua-11057	108	25	patients	patient	NOUN
aiua-11057	108	26	with	with	ADP
aiua-11057	108	27	stage	stage	NOUN
aiua-11057	108	28	i	i	PRON
aiua-11057	108	29	seminoma	seminoma	VERB
aiua-11057	108	30	:	:	PUNCT
aiua-11057	108	31	patterns	pattern	NOUN
aiua-11057	108	32	of	of	ADP
aiua-11057	108	33	relapse	relapse	NOUN
aiua-11057	108	34	and	and	CCONJ
aiua-11057	108	35	follow	follow	NOUN
aiua-11057	108	36	-	-	PUNCT
aiua-11057	108	37	up	up	NOUN
aiua-11057	108	38	.	.	PUNCT
aiua-11057	109	1	j	j	PROPN
aiua-11057	109	2	natl	natl	PROPN
aiua-11057	109	3	cancer	cancer	PROPN
aiua-11057	109	4	inst	inst	PROPN
aiua-11057	109	5	.	.	PUNCT
aiua-11057	110	1	2011	2011	NUM
aiua-11057	110	2	;	;	PUNCT
aiua-11057	110	3	103:241	103:241	NOUN
aiua-11057	110	4	-	-	SYM
aiua-11057	110	5	9	9	NUM
aiua-11057	110	6	.	.	NOUN
aiua-11057	110	7	4	4	NUM
aiua-11057	110	8	.	.	PUNCT
aiua-11057	110	9	glaser	glaser	PROPN
aiua-11057	110	10	sm	sm	PROPN
aiua-11057	110	11	,	,	PUNCT
aiua-11057	110	12	vargo	vargo	PROPN
aiua-11057	110	13	ja	ja	PROPN
aiua-11057	110	14	,	,	PUNCT
aiua-11057	110	15	balasubramani	balasubramani	PROPN
aiua-11057	110	16	gk	gk	PROPN
aiua-11057	110	17	,	,	PUNCT
aiua-11057	110	18	beriwal	beriwal	PROPN
aiua-11057	110	19	s.	s.	PROPN
aiua-11057	110	20	surveillance	surveillance	NOUN
aiua-11057	110	21	and	and	CCONJ
aiua-11057	110	22	radiation	radiation	NOUN
aiua-11057	110	23	therapy	therapy	NOUN
aiua-11057	110	24	for	for	ADP
aiua-11057	110	25	stage	stage	NOUN
aiua-11057	110	26	i	i	PRON
aiua-11057	110	27	seminoma	seminoma	VERB
aiua-11057	110	28	-	-	PUNCT
aiua-11057	110	29	have	have	AUX
aiua-11057	110	30	we	we	PRON
aiua-11057	110	31	learned	learn	VERB
aiua-11057	110	32	from	from	ADP
aiua-11057	110	33	the	the	DET
aiua-11057	110	34	evidence	evidence	NOUN
aiua-11057	110	35	?	?	PUNCT
aiua-11057	111	1	int	int	NOUN
aiua-11057	112	1	j	j	PROPN
aiua-11057	112	2	radiat	radiat	PROPN
aiua-11057	112	3	oncol	oncol	ADJ
aiua-11057	112	4	biol	biol	PROPN
aiua-11057	112	5	phys	phy	NOUN
aiua-11057	112	6	.	.	PUNCT
aiua-11057	112	7	2016	2016	NUM
aiua-11057	112	8	;	;	PUNCT
aiua-11057	112	9	94:75	94:75	NUM
aiua-11057	112	10	-	-	SYM
aiua-11057	112	11	84	84	NUM
aiua-11057	112	12	.	.	PUNCT
aiua-11057	113	1	5	5	X
aiua-11057	113	2	.	.	X
aiua-11057	113	3	seer	seer	PROPN
aiua-11057	113	4	cancer	cancer	NOUN
aiua-11057	113	5	statistics	statistic	NOUN
aiua-11057	113	6	factsheets	factsheet	NOUN
aiua-11057	113	7	:	:	PUNCT
aiua-11057	113	8	testicular	testicular	ADJ
aiua-11057	113	9	cancer	cancer	NOUN
aiua-11057	113	10	.	.	PUNCT
aiua-11057	114	1	national	national	PROPN
aiua-11057	114	2	cancer	cancer	PROPN
aiua-11057	114	3	institute	institute	PROPN
aiua-11057	114	4	.	.	PUNCT
aiua-11057	115	1	bethesda	bethesda	PROPN
aiua-11057	115	2	,	,	PUNCT
aiua-11057	115	3	md	md	PROPN
aiua-11057	115	4	.	.	PROPN
aiua-11057	115	5	2016	2016	NUM
aiua-11057	115	6	.	.	PUNCT
aiua-11057	116	1	6	6	NUM
aiua-11057	116	2	.	.	X
aiua-11057	116	3	andré	andré	PROPN
aiua-11057	116	4	marques	marques	PROPN
aiua-11057	116	5	-	-	PUNCT
aiua-11057	116	6	pinto	pinto	NOUN
aiua-11057	116	7	,	,	PUNCT
aiua-11057	116	8	ana	ana	PROPN
aiua-11057	116	9	inês	inês	PROPN
aiua-11057	116	10	gomes	gome	NOUN
aiua-11057	116	11	,	,	PUNCT
aiua-11057	116	12	joana	joana	PROPN
aiua-11057	116	13	febra	febra	PROPN
aiua-11057	116	14	,	,	PUNCT
aiua-11057	116	15	et	et	PROPN
aiua-11057	116	16	al	al	PROPN
aiua-11057	116	17	.	.	PROPN
aiua-11057	117	1	specialist	specialist	PROPN
aiua-11057	117	2	management	management	NOUN
aiua-11057	117	3	of	of	ADP
aiua-11057	117	4	testicular	testicular	ADJ
aiua-11057	117	5	cancer	cancer	NOUN
aiua-11057	117	6	:	:	PUNCT
aiua-11057	117	7	report	report	NOUN
aiua-11057	117	8	of	of	ADP
aiua-11057	117	9	the	the	DET
aiua-11057	117	10	last	last	ADJ
aiua-11057	117	11	10	10	NUM
aiua-11057	117	12	years	year	NOUN
aiua-11057	117	13	at	at	ADP
aiua-11057	117	14	a	a	DET
aiua-11057	117	15	portuguese	portuguese	ADJ
aiua-11057	117	16	tertiary	tertiary	ADJ
aiua-11057	117	17	referral	referral	ADJ
aiua-11057	117	18	academic	academic	ADJ
aiua-11057	117	19	centre	centre	NOUN
aiua-11057	117	20	.	.	PUNCT
aiua-11057	118	1	arch	arch	PROPN
aiua-11057	118	2	ital	ital	PROPN
aiua-11057	118	3	urol	urol	PROPN
aiua-11057	118	4	androl	androl	PROPN
aiua-11057	118	5	.	.	PROPN
aiua-11057	118	6	2021	2021	NUM
aiua-11057	118	7	;	;	PUNCT
aiua-11057	118	8	93:153	93:153	NUM
aiua-11057	118	9	-	-	SYM
aiua-11057	118	10	157	157	NUM
aiua-11057	118	11	.	.	PUNCT
aiua-11057	119	1	7	7	X
aiua-11057	119	2	.	.	X
aiua-11057	119	3	oliver	oliver	PROPN
aiua-11057	119	4	rt	rt	PROPN
aiua-11057	119	5	,	,	PUNCT
aiua-11057	119	6	mead	mead	VERB
aiua-11057	119	7	gm	gm	PROPN
aiua-11057	119	8	,	,	PUNCT
aiua-11057	119	9	rustin	rustin	PROPN
aiua-11057	119	10	gj	gj	PROPN
aiua-11057	119	11	,	,	PUNCT
aiua-11057	119	12	et	et	PROPN
aiua-11057	119	13	al	al	PROPN
aiua-11057	119	14	.	.	PROPN
aiua-11057	119	15	randomized	randomize	VERB
aiua-11057	119	16	trial	trial	NOUN
aiua-11057	119	17	of	of	ADP
aiua-11057	119	18	carboplatin	carboplatin	NOUN
aiua-11057	119	19	versus	versus	ADP
aiua-11057	119	20	radiotherapy	radiotherapy	NOUN
aiua-11057	119	21	for	for	ADP
aiua-11057	119	22	stage	stage	NOUN
aiua-11057	119	23	i	i	PRON
aiua-11057	119	24	seminoma	seminoma	VERB
aiua-11057	119	25	:	:	PUNCT
aiua-11057	119	26	mature	mature	VERB
aiua-11057	119	27	results	result	NOUN
aiua-11057	119	28	on	on	ADP
aiua-11057	119	29	relapse	relapse	NOUN
aiua-11057	119	30	and	and	CCONJ
aiua-11057	119	31	contralateral	contralateral	ADJ
aiua-11057	119	32	testis	testis	NOUN
aiua-11057	119	33	cancer	cancer	NOUN
aiua-11057	119	34	rates	rate	NOUN
aiua-11057	119	35	in	in	ADP
aiua-11057	119	36	mrc	mrc	NOUN
aiua-11057	119	37	te19	te19	PROPN
aiua-11057	119	38	/	/	SYM
aiua-11057	119	39	eortc	eortc	PROPN
aiua-11057	119	40	30982	30982	NUM
aiua-11057	119	41	study	study	NOUN
aiua-11057	119	42	(	(	PUNCT
aiua-11057	119	43	isrctn27163214	isrctn27163214	PROPN
aiua-11057	119	44	)	)	PUNCT
aiua-11057	119	45	.	.	PUNCT
aiua-11057	120	1	j	j	PROPN
aiua-11057	120	2	clin	clin	PROPN
aiua-11057	120	3	oncol	oncol	PROPN
aiua-11057	120	4	.	.	PUNCT
aiua-11057	121	1	2011	2011	NUM
aiua-11057	121	2	;	;	PUNCT
aiua-11057	121	3	29:957	29:957	NUM
aiua-11057	121	4	-	-	SYM
aiua-11057	121	5	62	62	NUM
aiua-11057	121	6	.	.	NOUN
aiua-11057	122	1	8	8	NUM
aiua-11057	122	2	.	.	PUNCT
aiua-11057	122	3	dieckmann	dieckmann	PROPN
aiua-11057	122	4	kp	kp	PROPN
aiua-11057	122	5	,	,	PUNCT
aiua-11057	122	6	dralle	dralle	NOUN
aiua-11057	122	7	-	-	PUNCT
aiua-11057	122	8	filiz	filiz	NOUN
aiua-11057	122	9	i	i	PROPN
aiua-11057	122	10	,	,	PUNCT
aiua-11057	122	11	matthies	matthie	NOUN
aiua-11057	122	12	c	c	NOUN
aiua-11057	122	13	,	,	PUNCT
aiua-11057	122	14	et	et	PROPN
aiua-11057	122	15	al	al	PROPN
aiua-11057	122	16	.	.	PROPN
aiua-11057	122	17	testicular	testicular	ADJ
aiua-11057	122	18	seminoma	seminoma	NOUN
aiua-11057	122	19	clinical	clinical	ADJ
aiua-11057	122	20	stage	stage	NOUN
aiua-11057	122	21	1	1	NUM
aiua-11057	122	22	:	:	PUNCT
aiua-11057	122	23	treatment	treatment	NOUN
aiua-11057	122	24	outcome	outcome	NOUN
aiua-11057	122	25	on	on	ADP
aiua-11057	122	26	a	a	DET
aiua-11057	122	27	routine	routine	ADJ
aiua-11057	122	28	care	care	NOUN
aiua-11057	122	29	level	level	NOUN
aiua-11057	122	30	.	.	PUNCT
aiua-11057	123	1	j	j	PROPN
aiua-11057	123	2	cancer	cancer	NOUN
aiua-11057	123	3	res	re	VERB
aiua-11057	123	4	clin	clin	PROPN
aiua-11057	123	5	oncol	oncol	PROPN
aiua-11057	123	6	.	.	PUNCT
aiua-11057	124	1	2016	2016	NUM
aiua-11057	124	2	;	;	PUNCT
aiua-11057	124	3	142:1599	142:1599	NUM
aiua-11057	124	4	-	-	SYM
aiua-11057	124	5	607	607	NUM
aiua-11057	124	6	.	.	PUNCT
aiua-11057	125	1	9	9	NUM
aiua-11057	125	2	.	.	NOUN
aiua-11057	125	3	tandstad	tandstad	PROPN
aiua-11057	125	4	t	t	PROPN
aiua-11057	125	5	,	,	PUNCT
aiua-11057	125	6	ståhl	ståhl	NOUN
aiua-11057	125	7	o	o	NOUN
aiua-11057	125	8	,	,	PUNCT
aiua-11057	125	9	dahl	dahl	PROPN
aiua-11057	125	10	o	o	NOUN
aiua-11057	125	11	,	,	PUNCT
aiua-11057	125	12	et	et	PROPN
aiua-11057	125	13	al	al	PROPN
aiua-11057	125	14	.	.	PUNCT
aiua-11057	126	1	treatment	treatment	NOUN
aiua-11057	126	2	of	of	ADP
aiua-11057	126	3	stage	stage	NOUN
aiua-11057	126	4	i	i	PRON
aiua-11057	126	5	seminoma	seminoma	VERB
aiua-11057	126	6	,	,	PUNCT
aiua-11057	126	7	with	with	ADP
aiua-11057	126	8	one	one	NUM
aiua-11057	126	9	course	course	NOUN
aiua-11057	126	10	of	of	ADP
aiua-11057	126	11	adjuvant	adjuvant	ADJ
aiua-11057	126	12	carboplatin	carboplatin	NOUN
aiua-11057	126	13	or	or	CCONJ
aiua-11057	126	14	surveillance	surveillance	NOUN
aiua-11057	126	15	,	,	PUNCT
aiua-11057	126	16	riskadapted	riskadapte	VERB
aiua-11057	126	17	recommendations	recommendation	NOUN
aiua-11057	126	18	implementing	implement	VERB
aiua-11057	126	19	patient	patient	ADJ
aiua-11057	126	20	autonomy	autonomy	NOUN
aiua-11057	126	21	:	:	PUNCT
aiua-11057	126	22	a	a	DET
aiua-11057	126	23	report	report	NOUN
aiua-11057	126	24	from	from	ADP
aiua-11057	126	25	the	the	DET
aiua-11057	126	26	swedish	swedish	ADJ
aiua-11057	126	27	and	and	CCONJ
aiua-11057	126	28	norwegian	norwegian	ADJ
aiua-11057	126	29	testicular	testicular	ADJ
aiua-11057	126	30	cancer	cancer	NOUN
aiua-11057	126	31	group	group	NOUN
aiua-11057	126	32	(	(	PUNCT
aiua-11057	126	33	swenoteca	swenoteca	PROPN
aiua-11057	126	34	)	)	PUNCT
aiua-11057	126	35	.	.	PUNCT
aiua-11057	127	1	ann	ann	PROPN
aiua-11057	127	2	oncol	oncol	PROPN
aiua-11057	127	3	.	.	PUNCT
aiua-11057	128	1	2016	2016	NUM
aiua-11057	128	2	;	;	PUNCT
aiua-11057	128	3	27:1299	27:1299	NUM
aiua-11057	128	4	-	-	SYM
aiua-11057	128	5	304	304	NUM
aiua-11057	128	6	.	.	PUNCT
aiua-11057	129	1	10	10	NUM
aiua-11057	129	2	.	.	PUNCT
aiua-11057	129	3	zengerling	zengerle	VERB
aiua-11057	130	1	f	f	X
aiua-11057	130	2	,	,	PUNCT
aiua-11057	130	3	kunath	kunath	ADP
aiua-11057	130	4	f	f	X
aiua-11057	130	5	,	,	PUNCT
aiua-11057	130	6	jensen	jensen	PROPN
aiua-11057	130	7	k	k	PROPN
aiua-11057	130	8	,	,	PUNCT
aiua-11057	130	9	et	et	PROPN
aiua-11057	130	10	al	al	PROPN
aiua-11057	130	11	.	.	PUNCT
aiua-11057	131	1	prognostic	prognostic	ADJ
aiua-11057	131	2	factors	factor	NOUN
aiua-11057	131	3	for	for	ADP
aiua-11057	131	4	tumor	tumor	NOUN
aiua-11057	131	5	recurrence	recurrence	NOUN
aiua-11057	131	6	in	in	ADP
aiua-11057	131	7	patients	patient	NOUN
aiua-11057	131	8	with	with	ADP
aiua-11057	131	9	clinical	clinical	ADJ
aiua-11057	131	10	stage	stage	NOUN
aiua-11057	131	11	i	i	PRON
aiua-11057	131	12	seminoma	seminoma	VERB
aiua-11057	131	13	undergoing	undergo	VERB
aiua-11057	131	14	surveillance	surveillance	NOUN
aiua-11057	131	15	-	-	PUNCT
aiua-11057	131	16	a	a	DET
aiua-11057	131	17	systematic	systematic	ADJ
aiua-11057	131	18	review	review	NOUN
aiua-11057	131	19	.	.	PUNCT
aiua-11057	132	1	urol	urol	PROPN
aiua-11057	132	2	oncol	oncol	PROPN
aiua-11057	132	3	.	.	PUNCT
aiua-11057	133	1	2018	2018	NUM
aiua-11057	133	2	;	;	PUNCT
aiua-11057	133	3	36:448	36:448	NUM
aiua-11057	133	4	-	-	SYM
aiua-11057	133	5	458	458	NUM
aiua-11057	133	6	.	.	PUNCT
aiua-11057	134	1	11	11	NUM
aiua-11057	134	2	.	.	PUNCT
aiua-11057	135	1	nccn	nccn	ADJ
aiua-11057	135	2	clinical	clinical	ADJ
aiua-11057	135	3	practice	practice	NOUN
aiua-11057	135	4	guidelines	guideline	NOUN
aiua-11057	135	5	in	in	ADP
aiua-11057	135	6	oncology	oncology	NOUN
aiua-11057	135	7	(	(	PUNCT
aiua-11057	135	8	nccn	nccn	PROPN
aiua-11057	135	9	guidelines	guideline	NOUN
aiua-11057	135	10	®	®	PROPN
aiua-11057	135	11	)	)	PUNCT
aiua-11057	135	12	for	for	ADP
aiua-11057	135	13	testicular	testicular	ADJ
aiua-11057	135	14	cancer	cancer	NOUN
aiua-11057	135	15	v.2.2022	v.2.2022	NOUN
aiua-11057	135	16	.	.	PUNCT
aiua-11057	136	1	©	©	PROPN
aiua-11057	136	2	national	national	PROPN
aiua-11057	136	3	comprehensive	comprehensive	ADJ
aiua-11057	136	4	cancer	cancer	NOUN
aiua-11057	136	5	network	network	PROPN
aiua-11057	136	6	,	,	PUNCT
aiua-11057	136	7	inc	inc	PROPN
aiua-11057	136	8	.	.	PROPN
aiua-11057	136	9	2022	2022	NUM
aiua-11057	136	10	.	.	PUNCT
aiua-11057	137	1	correspondence	correspondence	NOUN
aiua-11057	137	2	manar	manar	PROPN
aiua-11057	137	3	mahmoud	mahmoud	PROPN
aiua-11057	137	4	sayed	sayed	PROPN
aiua-11057	137	5	,	,	PUNCT
aiua-11057	137	6	md	md	PROPN
aiua-11057	137	7	manar.mahmoud54@yahoo.com	manar.mahmoud54@yahoo.com	PROPN
aiua-11057	137	8	azza	azza	PROPN
aiua-11057	137	9	mohamad	mohamad	PROPN
aiua-11057	137	10	nasr	nasr	PROPN
aiua-11057	137	11	,	,	PUNCT
aiua-11057	137	12	md	md	PROPN
aiua-11057	137	13	nasrazza2@hotmail.com	nasrazza2@hotmail.com	PROPN
aiua-11057	137	14	yasser	yasser	PROPN
aiua-11057	137	15	anwar	anwar	PROPN
aiua-11057	137	16	abdelazim	abdelazim	PROPN
aiua-11057	137	17	,	,	PUNCT
aiua-11057	137	18	md	md	PROPN
aiua-11057	137	19	(	(	PUNCT
aiua-11057	137	20	corresponding	correspond	VERB
aiua-11057	137	21	author	author	NOUN
aiua-11057	137	22	)	)	PUNCT
aiua-11057	138	1	yasser.anwar@nci.cu.edu.eg	yasser.anwar@nci.cu.edu.eg	PROPN
aiua-11057	138	2	department	department	NOUN
aiua-11057	138	3	of	of	ADP
aiua-11057	138	4	radiation	radiation	NOUN
aiua-11057	138	5	oncology	oncology	NOUN
aiua-11057	138	6	,	,	PUNCT
aiua-11057	138	7	national	national	PROPN
aiua-11057	138	8	cancer	cancer	PROPN
aiua-11057	138	9	institute	institute	PROPN
aiua-11057	138	10	,	,	PUNCT
aiua-11057	138	11	cairo	cairo	PROPN
aiua-11057	138	12	university	university	PROPN
aiua-11057	138	13	,	,	PUNCT
aiua-11057	138	14	egypt	egypt	PROPN
aiua-11057	138	15	kasr	kasr	PROPN
aiua-11057	139	1	el	el	PROPN
aiua-11057	139	2	ainy	ainy	PROPN
aiua-11057	139	3	street	street	PROPN
aiua-11057	139	4	,	,	PUNCT
aiua-11057	139	5	cairo	cairo	PROPN
aiua-11057	139	6	,	,	PUNCT
aiua-11057	139	7	egypt	egypt	PROPN
aiua-11057	139	8	,	,	PUNCT
aiua-11057	139	9	11796	11796	NUM
aiua-11057	139	10	ibtesam	ibtesam	PROPN
aiua-11057	139	11	mohamad	mohamad	PROPN
aiua-11057	139	12	saad	saad	PROPN
aiua-11057	139	13	eldin	eldin	PROPN
aiua-11057	139	14	,	,	PUNCT
aiua-11057	139	15	md	md	PROPN
aiua-11057	139	16	ibtessamsaad@yahoo.com	ibtessamsaad@yahoo.com	PROPN
aiua-11057	139	17	department	department	PROPN
aiua-11057	139	18	of	of	ADP
aiua-11057	139	19	clinical	clinical	ADJ
aiua-11057	139	20	oncology	oncology	NOUN
aiua-11057	139	21	,	,	PUNCT
aiua-11057	139	22	faculty	faculty	NOUN
aiua-11057	139	23	of	of	ADP
aiua-11057	139	24	medicine	medicine	NOUN
aiua-11057	139	25	,	,	PUNCT
aiua-11057	139	26	cairo	cairo	PROPN
aiua-11057	139	27	university	university	PROPN
aiua-11057	139	28	,	,	PUNCT
aiua-11057	140	1	egypt	egypt	PROPN
aiua-11057	140	2	al	al	PROPN
aiua-11057	140	3	kasr	kasr	PROPN
aiua-11057	141	1	el	el	PROPN
aiua-11057	141	2	ainy	ainy	PROPN
aiua-11057	141	3	,	,	PUNCT
aiua-11057	141	4	old	old	ADJ
aiua-11057	141	5	cairo	cairo	PROPN
aiua-11057	141	6	,	,	PUNCT
aiua-11057	141	7	egypt	egypt	PROPN
aiua-11057	141	8	conflict	conflict	NOUN
aiua-11057	141	9	of	of	ADP
aiua-11057	141	10	interest	interest	NOUN
aiua-11057	141	11	:	:	PUNCT
aiua-11057	141	12	the	the	DET
aiua-11057	141	13	authors	author	NOUN
aiua-11057	141	14	declare	declare	VERB
aiua-11057	141	15	no	no	DET
aiua-11057	141	16	potential	potential	ADJ
aiua-11057	141	17	conflict	conflict	NOUN
aiua-11057	141	18	of	of	ADP
aiua-11057	141	19	interest	interest	NOUN
aiua-11057	141	20	.	.	PUNCT